NCT00960219
D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia No drug interventions treatment 2 completed NCT00491569
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia No drug interventions treatment 2 completed NCT00276263
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia treatment 2 withdrawn NCT00328276
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia No drug interventions treatment 2 completed NCT00488319
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. No drug interventions treatment 3 completed NCT00572247
The Psychiatric Rehabilitation Approach to Weight Loss No drug interventions Not Available Not Available completed NCT04608032
Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia No drug interventions other Not Available recruiting NCT01606436
A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia basic_science 1 completed NCT02655172
Have a Good Grasp of the Worldthe World No drug interventions other Not Available completed NCT00660595
Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose No drug interventions treatment 3 terminated NCT02654405
Sodium Butyrate For Improving Cognitive Function In Schizophrenia No drug interventions treatment 2 / 3 withdrawn NCT00600756
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone No drug interventions treatment 3 completed NCT02525315
Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations No drug interventions treatment 2 completed NCT01279213
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia No drug interventions treatment 4 completed NCT02544516
Upside Down, Give me the Handle No drug interventions Not Available Not Available completed NCT00088465
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT00088491
Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia treatment 3 completed NCT05164289
Interest of EMDR Schizophrenic Disorders No drug interventions Not Available Not Available terminated NCT01729650
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) No drug interventions prevention Not Available completed NCT00485823
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia No drug interventions treatment 4 completed NCT00161408
Psychological Intervention for Relapse Prevention in First Episode Schizophrenia No drug interventions treatment Not Available unknown_status NCT01852331
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00206115
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia treatment 3 completed NCT00018837
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome No drug interventions Not Available Not Available completed NCT03010865
Sodium Butyrate For Improving Cognitive Function In Schizophrenia No drug interventions treatment 2 / 3 withdrawn NCT01567943
Contingency Management of Alcohol Abuse in the Severely Mentally ILL No drug interventions treatment Not Available completed NCT00440843
Zyprexa and Task Engagement in Schizophrenia No drug interventions treatment 3 withdrawn NCT00208143
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia treatment 4 completed NCT03446703
SCIT Versus TAR for Outpatients With Schizophrenia No drug interventions treatment Not Available completed NCT02001103
Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia No drug interventions treatment 3 unknown_status NCT00861003
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder No drug interventions Not Available Not Available unknown_status NCT05830903
Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques No drug interventions treatment Not Available recruiting NCT02625103
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. No drug interventions health_services_research 4 completed NCT01391403
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia No drug interventions treatment 3 completed NCT03285503
PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia No drug interventions other 1 completed NCT00053703
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) treatment 4 completed NCT03333603
Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients No drug interventions treatment 4 completed NCT05628103
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication No drug interventions treatment 3 completed NCT00307203
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke treatment 4 completed NCT04268303
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia No drug interventions treatment 3 completed NCT03090503
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up No drug interventions treatment 4 unknown_status NCT00108303
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes No drug interventions Not Available Not Available completed NCT02916303
Cost-effectiveness of Interventions in First-episode Psychosis No drug interventions Not Available Not Available unknown_status NCT03542903
ECT in Ultra-resistant Schizophrenia No drug interventions treatment Not Available unknown_status NCT01568203
First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia No drug interventions basic_science 1 terminated NCT01491490
Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine No drug interventions treatment 2 terminated NCT00448890
Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers No drug interventions treatment 1 completed NCT01409590
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications No drug interventions supportive_care Not Available completed NCT00922090
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended No drug interventions Not Available Not Available completed NCT03999190
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia No drug interventions Not Available Not Available withdrawn NCT00585390
Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia No drug interventions treatment 2 / 3 completed NCT02986490
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs No drug interventions prevention Not Available unknown_status NCT01232790
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia No drug interventions treatment Not Available completed NCT01143090
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder No drug interventions treatment 3 completed NCT06504290
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 No drug interventions treatment 1 recruiting NCT05036590
Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial. No drug interventions other Not Available recruiting NCT00885690
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA) No drug interventions treatment Not Available terminated NCT00148590
Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia prevention 3 terminated NCT01897064
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia. No drug interventions treatment Not Available completed NCT03953664
The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00569764
Effect on Metabolic Parameters of Abilify in SPR No drug interventions Not Available Not Available unknown_status NCT03146364
Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia No drug interventions diagnostic Not Available unknown_status NCT00857064
Subjective Well Being of Schizophrenic Patients in Greece No drug interventions Not Available Not Available completed NCT00649064
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs No drug interventions treatment 4 completed NCT05542264
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT01451164
A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia No drug interventions treatment 2 / 3 completed NCT00207064
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia diagnostic Not Available completed NCT01995864
Critical Time Intervention-Task Shifting: Randomized Controlled Trial No drug interventions health_services_research Not Available completed NCT02415764
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant No drug interventions health_services_research 1 completed NCT02105064
Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01955564
A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers. No drug interventions treatment 1 completed NCT02810964
Sulforaphane to Reduce Symptoms of Schizophrenia No drug interventions treatment 2 completed NCT05646264
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia No drug interventions treatment 4 recruiting NCT03302364
A Research in Pharmacogenomics and Accurate Medication of Risperidone No drug interventions Not Available Not Available unknown_status NCT00483964
A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia No drug interventions treatment 2 completed NCT02775864
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia No drug interventions Not Available Not Available completed NCT02764164
Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS) No drug interventions treatment Not Available terminated NCT03198364
Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI No drug interventions health_services_research Not Available completed NCT02484521
Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration No drug interventions basic_science Not Available completed NCT00088621
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia treatment 2 completed NCT05516121
VLT-015 in Patients With Schizophrenia No drug interventions other 1 completed NCT00138021
Cognitive Remediation in Supported Employment at Human Service Center (HSC) No drug interventions treatment Not Available unknown_status NCT01891721
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT00290121
Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics prevention 4 completed NCT01317121
Multi-site Communication Deficits in Schizophrenia No drug interventions Not Available Not Available completed NCT00435721
Families Coping With Mental Illness Program No drug interventions educational_counseling_training 1 unknown_status NCT00892021
Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder No drug interventions other 1 withdrawn NCT06384521
Lifestyle MIND- Feasibility of Wait-list Control No drug interventions treatment Not Available not_yet_recruiting NCT00918021
Polypharmacy in Clozapine-resistant Schizophrenia No drug interventions treatment 4 completed NCT00685321
Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia No drug interventions treatment Not Available unknown_status NCT02968121
Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia No drug interventions health_services_research 1 terminated NCT04917302
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia No drug interventions treatment 2 recruiting NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain No drug interventions treatment 2 completed NCT00169702
The Effect of a Weight Management Program During Treatment With Olanzapine No drug interventions prevention Not Available completed NCT01315002
Nicotine Effects on Endophenotypes of Schizophrenia No drug interventions basic_science Not Available completed NCT00254202
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia treatment 3 completed NCT01733602
tDCS to Enhance Cognitive Training in Schizophrenia No drug interventions treatment 1 / 2 completed NCT02035202
Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness No drug interventions treatment Not Available completed NCT02650102
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment No drug interventions basic_science 1 / 2 unknown_status NCT00455702
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia No drug interventions treatment 4 completed NCT00061802
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT06058702
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans No drug interventions other 1 not_yet_recruiting NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia No drug interventions treatment 3 recruiting NCT00211302
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) treatment Not Available terminated NCT00484302
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis No drug interventions treatment Not Available completed NCT01001702
Oral Aripiprazole Open-Label Rollover Study No drug interventions treatment 3 completed NCT00299702
Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia No drug interventions treatment 4 completed NCT01892384
Safety and Tolerability of BI 409306 in Patients With Schizophrenia No drug interventions treatment 1 completed NCT02287584
Confirmatory Study of DSP-5423P in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02435784
The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong Kong No drug interventions supportive_care Not Available completed NCT06486584
Contingency Management for Problematic Behavior Reduction in the Community No drug interventions other Not Available active_not_recruiting NCT04012684
rTMS on Mismatch Negativity of Schizophrenia No drug interventions treatment Not Available unknown_status NCT05229484
Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia No drug interventions supportive_care Not Available completed NCT02687984
PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT00848484
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED) No drug interventions treatment 2 completed NCT00791284
A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function No drug interventions treatment 1 completed NCT05957484
The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia No drug interventions treatment Not Available recruiting NCT06067984
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT04781179
Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT04907279
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) No drug interventions Not Available Not Available unknown_status NCT00463879
Galantamine for Cognitive Deficits in Schizophrenia No drug interventions treatment 2 / 3 completed NCT01249079
Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan No drug interventions Not Available Not Available unknown_status NCT03178279
The Evaluation of the Use of a New Physical Health Plan No drug interventions health_services_research Not Available completed NCT03504579
Rt-fMRI Neurofeedback and AH in Schizophrenia No drug interventions other Not Available completed NCT00102479
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents treatment 2 completed NCT06471179
Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments No drug interventions Not Available Not Available not_yet_recruiting NCT00215579
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence treatment 4 completed NCT01003379
TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia No drug interventions treatment 2 completed NCT01160679
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT06226779
Baduanjin Versus Brisk Walking for Cognition in Schizophrenia No drug interventions treatment Not Available recruiting NCT00141479
To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox treatment 2 completed NCT00524979
Digital Voice Analysis in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT03338179
Evaluation of Metamemory in Patients With Schizophrenia No drug interventions basic_science Not Available completed NCT02398279
L-arginine add-on Therapy in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT02868879
Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia No drug interventions Not Available Not Available completed NCT01234779
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia No drug interventions treatment 2 completed NCT00604279
A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia No drug interventions treatment 3 completed NCT02127879
Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT01104779
Safety and Efficacy of Cariprazine in Schizophrenia No drug interventions treatment 3 completed NCT02199743
Lurasidone Effects on Tissue Glutamate in Schizophrenia No drug interventions treatment 4 completed NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia No drug interventions treatment 4 completed NCT00265343
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) treatment 3 completed NCT00396643
Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis No drug interventions prevention 4 completed NCT02333487
Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700 No drug interventions treatment 1 completed NCT01758887
Antipsychotic Discontinuation in High-risk Subjects No drug interventions Not Available Not Available withdrawn NCT00044187
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder treatment 4 completed NCT04158687
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia treatment 2 completed NCT00843687
A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients. No drug interventions treatment 3 completed NCT01133587
Patient Guided Psychiatric Admissions No drug interventions prevention Not Available completed NCT00236587
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia No drug interventions treatment 3 completed NCT00193687
Bifeprunox in the Treatment of Schizophrenia treatment 3 completed NCT02901587
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder treatment 1 completed NCT01315587
Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia No drug interventions treatment 2 unknown_status NCT00204087
Psychological Intervention for Persons in the Early Initial Prodromal State No drug interventions treatment 3 unknown_status NCT00493233
Antipsychotic Polypharmacy in Schizophrenia No drug interventions treatment Not Available completed NCT00051233
Treatment of Schizophrenia Through Internet-Based Psychoeducation No drug interventions treatment 2 completed NCT00692133
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment No drug interventions Not Available Not Available completed NCT00345033
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia No drug interventions treatment 4 completed NCT02254733
Assertive Community Treatment With CBT and SST for Schizophrenia No drug interventions treatment Not Available completed NCT00423033
Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients No drug interventions Not Available Not Available completed NCT03263533
HDAC Inhibitor Augmentation to Clozapine treatment 0 withdrawn NCT01945333
Personalized and Scalable Cognitive Remediation Approaches No drug interventions treatment Not Available completed NCT00069433
Enhancing the Outcome of Skills Training for People With Schizophrenia No drug interventions treatment Not Available completed NCT00615433
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia No drug interventions treatment 3 completed NCT06304233
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease No drug interventions Not Available Not Available recruiting NCT05086133
cTBS on First-episode Drug Naive Patients With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT05174533
Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03702933
D-serine in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT01299454
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects treatment 1 completed NCT03935854
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness No drug interventions treatment Not Available completed NCT01244854
Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness No drug interventions health_services_research Not Available completed NCT03526354
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder treatment 4 completed NCT01234454
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI basic_science Not Available completed NCT02050854
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia No drug interventions Not Available Not Available completed NCT00805454
Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712 No drug interventions basic_science 1 completed NCT04822051
The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia Caregivers No drug interventions supportive_care Not Available completed NCT03930251
Cognitive Remediation for Coordinated Specialty Care No drug interventions treatment Not Available completed NCT04987151
The Effects of Different Modalities of Exercise in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT00753051
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT) No drug interventions treatment Not Available completed NCT00758251
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment No drug interventions Not Available Not Available completed NCT01149551
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness No drug interventions Not Available Not Available completed NCT06275451
Qualitative Study of Emotional Regulation in Schizophrenia No drug interventions Not Available Not Available recruiting NCT00330551
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia No drug interventions treatment 4 completed NCT03414151
Gut Microbiome in AP Naive No drug interventions Not Available Not Available unknown_status NCT03629951
A Study for Schizophrenia Relapse Prediction No drug interventions Not Available Not Available completed NCT00300651
Trial of Cognitive Behavioral Therapy for Schizophrenia No drug interventions treatment 3 unknown_status NCT01006551
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders treatment 2 completed NCT00265551
Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia treatment 2 completed NCT05053451
Brain Stimulation, Clinical Symptoms and Cognition No drug interventions treatment Not Available completed NCT00419653
Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy No drug interventions treatment 4 terminated NCT01354353
A Study of Safety and Tolerability in Subjects With Schizophrenia other 1 completed NCT05724953
Alexithymia Intervention for Suicide No drug interventions treatment 1 recruiting NCT03973853
How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT01509053
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole treatment 3 terminated NCT00236353
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 3 completed NCT03847753
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions No drug interventions Not Available Not Available completed NCT01454453
Optimisation of Antipsychotic Drug Use in Older People No drug interventions treatment 4 terminated NCT01609153
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy treatment 4 completed NCT03623477
Can Cognitive Training Decrease Reactive Aggression? No drug interventions treatment Not Available completed NCT01010477
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia treatment 4 completed NCT04318977
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia No drug interventions treatment Not Available recruiting NCT05449977
Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00234377
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02476877
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse No drug interventions Not Available Not Available completed NCT01028677
Oxytocin Treatment of Schizophrenia treatment Not Available completed NCT00074477
Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00715377
Anticholinergic Burden in Schizophrenia No drug interventions treatment Not Available terminated NCT05345977
eMotiph: E-mental Health Solution for Patients With Schizophrenia No drug interventions device_feasibility Not Available completed NCT02505477
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine treatment 4 completed NCT00391677
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia No drug interventions treatment Not Available completed NCT01149577
Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients basic_science 4 completed NCT01400477
Nicotinic Receptors and Schizophrenia treatment 2 completed NCT00333177
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia No drug interventions treatment 4 completed NCT00590577
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01677377
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy treatment 2 completed NCT00621777
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder No drug interventions treatment 4 completed NCT00560677
Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study) No drug interventions Not Available Not Available unknown_status NCT01321177
An Integrated Program for the Treatment of First Episode of Psychosis No drug interventions treatment Not Available completed NCT04941677
Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control No drug interventions Not Available Not Available completed NCT00148447
The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia treatment 3 completed NCT02661347
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia treatment Not Available withdrawn NCT00141947
Bexarotene Treatment in Schizophrenia treatment 3 unknown_status NCT00174447
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 treatment 3 completed NCT00206947
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia treatment 2 terminated NCT00403247
Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT01795547
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia treatment 3 completed NCT00145847
Naltrexone Treatment of Alcohol Abuse in Schizophrenia No drug interventions treatment 4 completed NCT02739347
Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia No drug interventions treatment Not Available terminated NCT05389345
tDCS and Executive Function Training for Schizophrenia No drug interventions treatment Not Available withdrawn NCT02288845
Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia basic_science 2 completed NCT02841345
Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients No drug interventions basic_science Not Available unknown_status NCT03896945
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia No drug interventions treatment 2 / 3 terminated NCT02850445
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients treatment Not Available unknown_status NCT00641745
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia No drug interventions treatment 3 completed NCT00535145
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease No drug interventions treatment 4 completed NCT00864045
Sertindole in Asian Patients With Schizophrenia No drug interventions treatment 3 completed NCT05837598
Adapting the Tumor Board Model for Mental Illness and Cancer No drug interventions supportive_care Not Available recruiting NCT00818298
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study No drug interventions treatment Not Available completed NCT01310998
Acute Psychological Effects of High Intensity Exercise With Schizophrenia No drug interventions health_services_research Not Available completed NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia treatment 2 recruiting NCT01738698
Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia treatment 3 terminated NCT04040998
Compensatory Cognitive Training For Schizophrenia No drug interventions treatment Not Available completed NCT01866098
Naltrexone for Antipsychotic-Induced Weight Gain treatment Not Available completed NCT00051298
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia treatment 3 completed NCT01749098
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers basic_science 1 completed NCT04629898
Level of Immersion of Virtual Reality and Cognition and Motor Performance in Patients of Schizophrenia Spectrum Disorder No drug interventions health_services_research Not Available completed NCT04495998
The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia No drug interventions supportive_care Not Available completed NCT03940898
The Mid-term Effect of Repeated Transcranial Magnetic Stimulation on Schizophrenia No drug interventions treatment Not Available completed NCT00338598
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism No drug interventions treatment 2 completed NCT00001198
Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia No drug interventions Not Available Not Available terminated NCT02332798
Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia treatment 1 completed NCT03166098
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders No drug interventions Not Available Not Available completed NCT05859698
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia treatment 4 active_not_recruiting NCT01595698
Schizophrenia and Physical Exercise No drug interventions treatment Not Available completed NCT04510298
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia No drug interventions treatment 1 completed NCT00534898
Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients No drug interventions treatment 3 withdrawn NCT01361698
Illness Management and Recovery (IMR) in Danish Community Mental Health Centres No drug interventions treatment Not Available completed NCT00486798
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis No drug interventions treatment 3 terminated NCT00875498
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT02591498
Computerized Cognitive Training for Schizophrenia in Brazil No drug interventions treatment 3 unknown_status NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder treatment 3 unknown_status NCT01527305
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia treatment 4 completed NCT02970305
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) treatment 2 completed NCT00227305
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder treatment 3 completed NCT00757705
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia No drug interventions treatment 4 completed NCT06007105
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities No drug interventions supportive_care Not Available recruiting NCT00772005
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia No drug interventions treatment 2 completed NCT01323205
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia treatment 2 completed NCT00528905
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia No drug interventions treatment 2 completed NCT01214005
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls No drug interventions basic_science 2 completed NCT00761605
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants No drug interventions treatment 4 completed NCT00034905
A Comparison of Seroquel vs. Risperidone in Schizophrenia treatment 4 completed NCT00757497
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia No drug interventions treatment 1 terminated NCT01699997
Oxytocin as Adjunctive Therapy for Schizophrenia treatment 2 completed NCT03860597
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia supportive_care 4 completed NCT04268797
TMS in Treatment of Schizophrenia Negative Symptoms No drug interventions treatment Not Available unknown_status NCT00861497
Bifeprunox Extension to Extension Study in Patients With Schizophrenia No drug interventions treatment 3 terminated NCT02686697
Carnosine and Cognitive Training in Schizophrenia treatment 2 / 3 completed NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia treatment 2 / 3 completed NCT06494397
Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions treatment 1 not_yet_recruiting NCT06021197
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia No drug interventions treatment 2 recruiting NCT04147897
Implementing mHealth for Schizophrenia in Community Mental Health Settings No drug interventions treatment Not Available active_not_recruiting NCT03509597
Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia No drug interventions treatment Not Available unknown_status NCT00392197
Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- No drug interventions treatment 4 completed NCT06045897
EEG Microstates Across At-Risk Mental States No drug interventions diagnostic Not Available recruiting NCT02357797
Adjunctive Vortioxetine in Schizophrenia treatment 4 active_not_recruiting NCT00063297
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia No drug interventions treatment 2 completed NCT01810783
Brexpiprazole in Patients With Schizophrenia treatment 3 completed NCT02930083
Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia No drug interventions Not Available Not Available completed NCT01487083
A Long-Term Study in Schizophrenia treatment 3 terminated NCT05380583
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study No drug interventions treatment Not Available recruiting NCT00044083
Clinical Trial of Tolcapone for Cognition in Schizophrenia other 2 terminated NCT04822883
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia No drug interventions treatment 2 completed NCT00536783
Schizophrenia Sensory Gating Deficit With Quetiapine No drug interventions Not Available Not Available completed NCT06315283
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia treatment 1 recruiting NCT00197483
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia Not Available Not Available suspended NCT05936983
Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia No drug interventions Not Available Not Available completed NCT00856583
Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use No drug interventions prevention 3 completed NCT00148083
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia treatment 3 completed NCT01032083
Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia treatment 4 completed NCT02621983
Aerobic Exercise for Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT03617783
Prebiotic Treatment in People With Schizophrenia - Pilot Study No drug interventions other 4 completed NCT00204061
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis treatment 4 completed NCT05667961
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation No drug interventions Not Available Not Available recruiting NCT04562961
Diagnostic Announcement to Relatives of Patients With Schizophrenia No drug interventions other Not Available unknown_status NCT00012961
Improving Health Services for Veterans With Schizophrenia No drug interventions Not Available Not Available completed NCT00561561
Sensorimotor Gating in Schizophrenia No drug interventions basic_science Not Available completed NCT06276361
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia treatment 1 recruiting NCT00937261
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning No drug interventions treatment 4 unknown_status NCT02282761
A Trial to Assess the Antipsychotic Efficacy of ITI-007 treatment 3 completed NCT00587561
Efficacy of Social Cognition Training in Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT00237861
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia treatment 4 completed NCT04659161
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) treatment 3 completed NCT01714661
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy treatment 3 completed NCT05784961
Impact of tDCS on Cannabis Craving in Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT02360228
STimulation to Improve Auditory haLLucinations No drug interventions treatment Not Available completed NCT00048828
Treating Drug-Resistant Childhood Schizophrenia treatment 4 completed NCT00444028
Staccato Loxapine Single Dose PK No drug interventions treatment 1 completed NCT05712928
eMove - Dance/Movement Therapy Study No drug interventions treatment Not Available completed NCT05571228
Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis No drug interventions treatment Not Available active_not_recruiting NCT03588728
tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia No drug interventions treatment Not Available terminated NCT05623228
The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training. No drug interventions treatment 2 completed NCT05537428
Song-making In a Group (SING) No drug interventions basic_science Not Available completed NCT01446328
Bergen Psychosis Project 2 - The Best Intro Study treatment 4 completed NCT02694328
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) treatment 3 completed NCT00511628
Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia No drug interventions Not Available Not Available terminated NCT01246128
Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics No drug interventions Not Available Not Available withdrawn NCT01568528
Oxytocin as Adjunctive Treatment of Schizophrenia treatment 2 completed NCT02075528
Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER treatment 4 completed NCT01805128
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum No drug interventions Not Available Not Available completed NCT00988728
Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) treatment 2 withdrawn NCT02007928
Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic No drug interventions other Not Available completed NCT00728728
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia No drug interventions treatment 2 completed NCT03817528
ITI-007 (Lumateperone Tosylate) for Schizophrenia treatment 2 terminated NCT04418011
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders No drug interventions treatment Not Available completed NCT02124811
Minocycline Augmentation to Clozapine treatment 4 completed NCT01972711
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics treatment 1 completed NCT05402111
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard treatment 1 completed NCT00168311
A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT00615511
Efficacy of Pregnenolone in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00510211
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. No drug interventions Not Available Not Available completed NCT00975611
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation treatment 4 terminated NCT03788811
ERG Components in Schizophrenia and Bipolar Disorder Type I No drug interventions Not Available Not Available active_not_recruiting NCT01610011
Acute Glycine Pharmacodynamic Study No drug interventions basic_science Not Available completed NCT05580211
Neuromodulation for Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT05545111
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia No drug interventions treatment 2 recruiting NCT06251193
Optimizing CBSST With Executive Function Training for Schizophrenia No drug interventions treatment Not Available recruiting NCT02455193
Neuronal Effects of Exercise in Schizophrenia No drug interventions other Not Available recruiting NCT01329393
Benefits Management for People With Psychiatric Disabilities No drug interventions treatment 1 completed NCT00650793
A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia No drug interventions treatment 3 completed NCT04113993
Bazedoxifene -Treatment for Women With Schizophrenia treatment 4 recruiting NCT00952393
Nicotinic Receptors and Schizophrenia No drug interventions treatment 1 completed NCT00791193
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR No drug interventions treatment 1 completed NCT04605393
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study basic_science Not Available completed NCT01328093
A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients treatment 3 terminated NCT06370793
Ningbo Schizophrenia Cohort No drug interventions Not Available Not Available active_not_recruiting NCT00197093
In-Patient Study In Schizophrenic Patients treatment 1 completed NCT00043693
Family Intervention for Mental Illness and Substance Abuse No drug interventions treatment Not Available completed NCT01614093
Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia treatment 4 completed NCT01585493
CHANGE -it is About Life No drug interventions prevention 3 completed NCT00216671
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode treatment 4 completed NCT02950571
RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting No drug interventions supportive_care Not Available completed NCT05498571
Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00001771
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers No drug interventions Not Available Not Available completed NCT01541371
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia treatment 3 completed NCT06387771
Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia treatment 2 recruiting NCT00212771
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) treatment 3 completed NCT01670071
A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia treatment 4 terminated NCT00000371
Trial of D-Cycloserine in Schizophrenia treatment 3 completed NCT04076371
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia treatment Not Available completed NCT03132571
Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia treatment 2 terminated NCT04783571
Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia No drug interventions other Not Available recruiting NCT02118571
Schizophrenia Cognition Scale Development No drug interventions Not Available Not Available completed NCT01425671
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States No drug interventions Not Available Not Available completed NCT02634671
Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome No drug interventions diagnostic Not Available completed NCT00480571
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder No drug interventions treatment 2 completed NCT01378078
Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00923078
Neurophysiological Targets for Cognitive Training in Schizophrenia No drug interventions treatment Not Available completed NCT01821378
Lurasidone Low-Dose - High-Dose Study Study treatment 3 completed NCT03528278
Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards No drug interventions Not Available Not Available completed NCT00214578
Seroquel on Glucose Metabolism treatment 4 completed NCT03198078
Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia treatment 3 completed NCT03751488
A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients treatment 1 completed NCT02983188
Berberine as Adjuvant Treatment for Schizophrenia Patients treatment 2 / 3 completed NCT00203788
Improving Work Outcome in People With Recent-onset Schizophrenia treatment 4 completed NCT03757988
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life No drug interventions treatment Not Available completed NCT00507988
Complex Problem Solving Training in Schizophrenic Patients No drug interventions treatment Not Available completed NCT06386588
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia No drug interventions basic_science Not Available not_yet_recruiting NCT02140788
Effects of Metformin and Fish Oil on Treatment With Clozapine other 4 terminated NCT04038788
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00543088
Effectiveness of Anti-Psychotic in GPs Setting No drug interventions Not Available Not Available completed NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia treatment 4 completed NCT04432688
The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients Not Available Not Available completed NCT01282307
Improving Insight in Patients Diagnosed With Schizophrenia No drug interventions treatment Not Available completed NCT02245607
Compensatory Cognitive Training in Clinical High Risk Latino Youth No drug interventions treatment Not Available unknown_status NCT01888107
Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT01903707
Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available unknown_status NCT04094207
Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia treatment 1 / 2 completed NCT05866107
App and Body Fat Scale in the Management of Overweight Patients No drug interventions treatment Not Available not_yet_recruiting NCT05766007
Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum No drug interventions Not Available Not Available recruiting NCT00919607
Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients No drug interventions Not Available 1 completed NCT00458107
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects No drug interventions treatment 1 completed NCT00202007
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia treatment 2 completed NCT06361407
Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia No drug interventions basic_science Not Available not_yet_recruiting NCT05833009
Acupuncture Treatment for Schizophrenia-related Central Obesity No drug interventions treatment Not Available recruiting NCT05106309
Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants treatment 1 completed NCT03862209
Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia No drug interventions health_services_research Not Available unknown_status NCT05268809
Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet? No drug interventions basic_science Not Available recruiting NCT04430309
Baduanjin on Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT01177709
Metformin for Weight Loss in Schizophrenia treatment Not Available terminated NCT00237809
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia treatment 3 completed NCT00870909
Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT04820309
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) treatment 3 completed NCT03854409
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder basic_science 1 completed NCT02511509
Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT00798109
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse No drug interventions treatment Not Available completed NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophrenia treatment 3 completed NCT06431009
The Danish Region Midt Schizophrenia Cohort No drug interventions Not Available Not Available recruiting NCT00453609
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) No drug interventions treatment 4 completed NCT02568709
Oxytocin MEG Study treatment 0 completed NCT03003156
50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia No drug interventions treatment Not Available completed NCT04421456
Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment treatment 2 terminated NCT02233556
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects Not Available Not Available unknown_status NCT04203056
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode treatment 4 terminated NCT04578756
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder treatment 3 recruiting NCT00239356
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials treatment 3 completed NCT01874756
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia treatment 2 terminated NCT01876056
Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis No drug interventions treatment Not Available completed NCT02151656
F17464 in Acute Schizophrenia Trial No drug interventions treatment 2 completed NCT02308956
Task Sharing for the Care of Severe Mental Disorders in a Low-income Country No drug interventions health_services_research 3 completed NCT06176456
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia No drug interventions treatment Not Available recruiting NCT00481156
Functional Neuroimaging Effects of Cognitive Remediation Training No drug interventions basic_science 3 completed NCT06446856
EVEN - Effects of VR on Empathy for Nature in Patients With Psychosis and Depressive Disorders No drug interventions Not Available Not Available recruiting NCT00737256
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence No drug interventions treatment 2 unknown_status NCT00001656
Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders treatment 4 completed NCT00119756
A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia treatment 3 completed NCT01235585
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) treatment 3 completed NCT03790085
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals diagnostic 0 unknown_status NCT04783285
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders No drug interventions treatment Not Available completed NCT00221585
The National Danish Schizophrenia Project No drug interventions Not Available Not Available unknown_status NCT00046085
Online Family Support and Education for Schizophrenia No drug interventions treatment Not Available completed NCT00796185
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations No drug interventions treatment 1 completed NCT05850585
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia treatment Not Available not_yet_recruiting NCT01626885
A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia treatment 2 / 3 completed NCT03571685
Sustainable Early Episode Clinic Study (SEEC) No drug interventions other Not Available completed NCT06527885
Lurasidone Non-Interventional Study in Schizophrenia Patients Not Available Not Available completed NCT01034085
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT01392885
Brain Health and Exercise in Schizophrenia No drug interventions Not Available Not Available recruiting NCT02282085
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia treatment 4 unknown_status NCT05725785
Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness No drug interventions supportive_care Not Available recruiting NCT03000985
Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms No drug interventions supportive_care Not Available unknown_status NCT03359785
A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia treatment 2 completed NCT01411085
Risperidone and Desipramine in Alcohol Use and Schizophrenia treatment 2 completed NCT00455715
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia No drug interventions treatment 4 completed NCT03708315
BXCL501 for Agitation in Schizophrenia treatment 2 recruiting NCT03781115
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia diagnostic 1 unknown_status NCT01686815
Cross-Sectional Iloperidone IVGTT No drug interventions Not Available Not Available completed NCT00395915
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia No drug interventions treatment 4 unknown_status NCT01383915
Clinical Risk State for Bipolar Disorder in Adolescents No drug interventions Not Available Not Available active_not_recruiting NCT06225115
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years No drug interventions treatment 1 recruiting NCT01529515
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia No drug interventions treatment 3 completed NCT01047215
Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine treatment 4 unknown_status NCT01903915
Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02131415
Real Life Assessment of Abilify Maintena No drug interventions Not Available Not Available terminated NCT04611737
Self-Determination Theory and Motivational Interviewing No drug interventions supportive_care Not Available completed NCT01903837
A Study of ALKS 3831 in Adults With Schizophrenia treatment 2 completed NCT03873337
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) treatment Not Available completed NCT01953237
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications No drug interventions health_services_research Not Available completed NCT02647437
Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia other Not Available recruiting NCT02205437
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00668837
A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305. No drug interventions treatment 3 completed NCT03943537
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders other 2 recruiting NCT00139737
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia treatment 3 completed NCT01611337
Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry No drug interventions other Not Available completed NCT00619437
Genetics of Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00560937
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia No drug interventions treatment Not Available completed NCT02832037
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia No drug interventions treatment 2 completed NCT02567032
Adult Study Oxytocin - Behavioral treatment 0 completed NCT04959032
Lumateperone for the Prevention of Relapse in Patients With Schizophrenia treatment 3 active_not_recruiting NCT00216632
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) treatment 4 completed NCT02002832
A Clinical Trial of Lurasidone in Treatment of Schizophrenia treatment 3 completed NCT02652832
Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels No drug interventions basic_science Not Available unknown_status NCT01663532
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia treatment 3 completed NCT02533232
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia treatment 1 unknown_status NCT01952132
Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects treatment 2 completed NCT03978832
Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone treatment 4 completed NCT05823532
Anti-Inflammatory Challenge in Schizophrenia basic_science 4 recruiting NCT01003132
Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis No drug interventions treatment Not Available completed NCT05017532
Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders No drug interventions treatment Not Available recruiting NCT02626832
Regulation of Arginine-vasopressin (AVP) No drug interventions diagnostic Not Available completed NCT05074732
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. No drug interventions Not Available Not Available recruiting NCT05538832
Remote State Representation in Early Psychosis No drug interventions treatment 0 recruiting NCT00249132
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia No drug interventions treatment 3 completed NCT03237052
Validating and Optimizing Model of Antipsychotics Selection No drug interventions treatment Not Available unknown_status NCT00839852
A Study of Cariprazine in Patients With Chronic Stable Schizophrenia No drug interventions treatment 2 completed NCT00495352
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia No drug interventions treatment 4 completed NCT04941352
Motivational Interviewing in Patients With Schizophrenia No drug interventions supportive_care Not Available completed NCT00644852
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone No drug interventions Not Available Not Available completed NCT05929352
Song-making In a Group (SING) No drug interventions basic_science Not Available recruiting NCT00980252
Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention No drug interventions Not Available Not Available completed NCT02104752
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia treatment 1 / 2 completed NCT00328952
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00287352
Study of Amantadine for Weight Stabilization During Olanzapine Treatment No drug interventions treatment 1 completed NCT03425552
A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment other 1 / 2 completed NCT02876900
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. treatment 3 completed NCT00013000
A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines No drug interventions treatment Not Available completed NCT01479400
Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study No drug interventions Not Available Not Available completed NCT00802100
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia No drug interventions treatment 4 completed NCT01779700
Fingolimod in Schizophrenia Patients treatment 2 completed NCT03711500
D-serine Augmentation of Neuroplasticity treatment 1 / 2 completed NCT00686400
A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia No drug interventions Not Available Not Available unknown_status NCT05848700
A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia treatment 1 completed NCT00847600
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia No drug interventions treatment 4 completed NCT05435300
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT01348100
Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients treatment 1 / 2 completed NCT02640300
Switching Antipsychotics: Abrupt Discontinuation Versus Overlap treatment 4 completed NCT00174200
Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone treatment Not Available completed NCT03568500
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic health_services_research 4 completed NCT00829400
Cognitive Training to Enhance VA Work Program Outcomes No drug interventions treatment Not Available completed NCT06440200
Exploring the Health Effects of Group Game-based Activities on Individuals With Chronic Mental Illness No drug interventions other Not Available enrolling_by_invitation NCT04191200
Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital No drug interventions Not Available Not Available completed NCT04951700
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia No drug interventions Not Available Not Available recruiting NCT01626859
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia treatment 2 / 3 completed NCT02796859
Siltuximab in Schizophrenia treatment 1 / 2 recruiting NCT03788759
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia treatment 2 / 3 completed NCT02932059
Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia No drug interventions other Not Available unknown_status NCT00740259
Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol No drug interventions treatment 4 completed NCT01503359
Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia No drug interventions treatment 2 completed NCT01981759
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions treatment 4 completed NCT01561859
Brain Imaging, Cognitive Enhancement and Early Schizophrenia No drug interventions treatment Not Available completed NCT01940159
A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia treatment 1 completed NCT02676375
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment treatment 4 completed NCT00960375
Smoking Cessation for Veterans With Severe and Persistent Mental Illness No drug interventions treatment 2 / 3 completed NCT02067975
Tryptophan MRI in People With Schizophrenia and Healthy Controls treatment 2 / 3 completed NCT00338975
Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia No drug interventions treatment Not Available completed NCT00306475
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? No drug interventions treatment 4 completed NCT04350775
Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia No drug interventions treatment Not Available completed NCT00712075
Functional Rehabilitation for Older Patients With Schizophrenia No drug interventions treatment Not Available terminated NCT02660775
Social Cognitive Assessment in Autism and Schizophrenia No drug interventions screening Not Available completed NCT00517075
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) No drug interventions treatment 2 terminated NCT00138775
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia treatment 2 unknown_status NCT01100775
Effects of Galantamine on Cognition prevention 2 completed NCT05124470
Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients No drug interventions basic_science Not Available completed NCT05463770
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia treatment 1 completed NCT00333970
Predictors of Response to Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available completed NCT01973270
Community-Based Cognitive Training in Early Schizophrenia No drug interventions treatment Not Available completed NCT00579670
Treatment of Schizophrenic Patients With Ziprasidone No drug interventions Not Available Not Available completed NCT03221270
Targeting Auditory Hallucinations With Alternating Current Stimulation No drug interventions treatment Not Available completed NCT05643170
An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia treatment 3 terminated NCT00259870
SB-773812 Administered In Adults With Schizophrenia No drug interventions treatment 2 completed NCT03048370
Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia No drug interventions basic_science Not Available completed NCT00761670
Efficacy Study on Cognitive Functions in Schizophrenic Patients No drug interventions treatment 4 completed NCT01078870
Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype diagnostic 4 unknown_status NCT00538070
A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia No drug interventions treatment Not Available completed NCT00788970
Shiatsu Adjuvant Therapy And Placebo For Schizophrenia No drug interventions treatment Not Available unknown_status NCT02477670
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia No drug interventions treatment 2 completed NCT00809770
Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill No drug interventions treatment Not Available completed NCT02267070
Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode No drug interventions treatment Not Available completed NCT00929370
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. No drug interventions treatment 1 terminated NCT01121042
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia treatment 3 completed NCT01634542
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia No drug interventions Not Available Not Available completed NCT02782442
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) No drug interventions treatment Not Available completed NCT02636842
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder treatment 1 completed NCT00487942
Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits No drug interventions treatment 2 completed NCT02417142
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia treatment 4 completed NCT03575442
"Art Therapy" in Acute Psychiatry No drug interventions screening Not Available unknown_status NCT00182442
Cognition, Functioning and Quality of Life treatment 4 completed NCT01169142
Study of Vitamin D in the Severely Mentally Ill No drug interventions treatment 4 completed NCT01244542
Pain and Schizophrenia No drug interventions health_services_research Not Available terminated NCT00018642
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder treatment Not Available completed NCT00538642
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone No drug interventions treatment Not Available completed NCT01387542
Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants treatment 4 completed NCT00108199
Generalization of Training in Schizophrenia No drug interventions Not Available Not Available completed NCT00457899
Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder No drug interventions treatment 3 terminated NCT01545999
Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT01614899
A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia treatment 3 completed NCT00782899
Four Dimensions in Schizophrenia No drug interventions Not Available Not Available completed NCT02439099
Retinoic Acid Homeostasis in Neuropsychiatric Diseases No drug interventions Not Available Not Available unknown_status NCT00425399
Shiatsu Adjuvant Therapy For Schizophrenia No drug interventions treatment Not Available completed NCT05358899
Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia No drug interventions treatment Not Available recruiting NCT01137799
The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients treatment 1 terminated NCT01870999
A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot treatment 1 completed NCT02108899
Retrieval Practice and Schizophrenia No drug interventions supportive_care Not Available suspended NCT03497299
Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia No drug interventions treatment 2 withdrawn NCT00645099
A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00286299
Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia No drug interventions treatment Not Available completed NCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? treatment 4 active_not_recruiting NCT01448499
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients treatment Not Available withdrawn NCT01898299
TDCS for Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT00823199
An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia No drug interventions treatment Not Available completed NCT00567099
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole No drug interventions treatment Not Available unknown_status NCT01511406
Cognitive Behavioral Therapy for Patients With an Early Psychosis No drug interventions treatment 2 completed NCT01368406
Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia No drug interventions prevention Not Available completed NCT00563706
Study Evaluating Vabicaserin in Subjects With Schizophrenia No drug interventions treatment 2 completed NCT03852706
EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED) No drug interventions other Not Available terminated NCT00789906
Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT05662306
C-Cog in Early Course Schizophrenia Study treatment 4 recruiting NCT00611806
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia No drug interventions treatment 4 completed NCT00470106
Improving Basic and Social Cognition in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT02121106
Remote Cognitive Remediation No drug interventions treatment Not Available completed NCT00139906
Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia treatment 2 completed NCT01192906
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) treatment 3 completed NCT00753506
Artemisinin to Reduce The Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT03068806
Brain Imaging, Attention, and Auditory Processing in Schizophrenia No drug interventions Not Available Not Available completed NCT06043206
Bariatric Surgery in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04598906
Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and Depression No drug interventions treatment Not Available completed NCT00155506
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios No drug interventions Not Available Not Available completed NCT05663749
Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics treatment 4 completed NCT01057849
Standard Comprehensive Intervention to Treat First-episode Schizophrenia treatment Not Available unknown_status NCT01094249
A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder Not Available 1 completed NCT04752449
Virtual Cognitive Behavioural Therapy for Psychosis No drug interventions treatment Not Available active_not_recruiting NCT00088049
Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia treatment 4 completed NCT00731549
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00232349
Efficacy of Galantamine to Treat Schizophrenia treatment 4 terminated NCT01312649
Feeling of Being in Control of One's Own Action No drug interventions basic_science Not Available completed NCT02507349
Person-Centered Versus Measurement-Based Care in Mental Health No drug interventions treatment Not Available completed NCT02160249
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) No drug interventions supportive_care Not Available completed NCT01298349
Perception Processing in Schizophrenia Patients and Normal Population No drug interventions Not Available Not Available completed NCT00312949
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia No drug interventions Not Available Not Available completed NCT06315049
Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness No drug interventions supportive_care Not Available completed NCT02663349
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness No drug interventions treatment Not Available completed NCT00338949
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes No drug interventions treatment 4 completed NCT03481049
Individualizing Incentives for Alcohol in the Severely Mentally Ill No drug interventions treatment Not Available active_not_recruiting NCT02768649
Single Ascending Dose Study of RBP-7000 treatment 1 completed NCT01111149
Varenicline and Smoking Cessation in Schizophrenia treatment 2 completed NCT05159349
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT00392249
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. No drug interventions treatment 1 / 2 unknown_status NCT03881449
DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole treatment 4 unknown_status NCT00155649
A Positional Cloning Study on Schizophrenia No drug interventions Not Available Not Available completed NCT00873249
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00268749
Glycine Treatment of Prodromal Symptoms treatment 2 completed NCT04476836
Animal-Assisted Therapy in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT03208036
Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness No drug interventions treatment Not Available completed NCT00155636
A Study on Etiological Factors of Schizophrenia No drug interventions Not Available Not Available terminated NCT05351736
Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) other 4 recruiting NCT06003036
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine No drug interventions basic_science Not Available recruiting NCT00212836
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) treatment 3 completed NCT02435836
A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia treatment 3 terminated NCT00392236
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers No drug interventions supportive_care Not Available completed NCT01534936
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary No drug interventions Not Available Not Available completed NCT00253136
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia treatment 3 completed NCT00063336
Treatment Response to Rehabilitation in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00320736
Galantamine for Cognition in People With Schizophrenia No drug interventions treatment 4 completed NCT01213836
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia treatment 4 completed NCT00314613
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal No drug interventions treatment 4 terminated NCT00791713
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER No drug interventions treatment 1 completed NCT00309413
A Clinical Trial on the Antipsychotic Properties of Cannabidiol No drug interventions treatment 2 completed NCT04284813
Families With Substance Use and Psychosis: A Pilot Study No drug interventions treatment Not Available completed NCT02815813
Lifestyle Intervention for Young Adults With Serious Mental Illness No drug interventions treatment Not Available completed NCT03049813
Virtual Reality Job Interview Training in Severe Mental Illness No drug interventions other Not Available completed NCT06245213
A Study of ANAVEX3-71 in Adults With Schizophrenia treatment 2 recruiting NCT01926613
Thinking Skills for Work in Severe Mental Illness No drug interventions treatment Not Available completed NCT00237913
Schizophrenia Trial of Aripiprazole treatment 3 completed NCT02202213
Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia No drug interventions treatment 1 completed NCT04742413
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study. No drug interventions Not Available Not Available terminated NCT02102113
Probing the Cannabinoid System in Individuals With a Family History of Psychosis other 0 active_not_recruiting NCT01623713
Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia treatment 2 completed NCT00102518
Aripiprazole Open-Label, Safety and Tolerability Study treatment 3 completed NCT00549718
Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia No drug interventions treatment 3 completed NCT00531518
Early Detection and Intervention for the Prevention of Psychosis No drug interventions prevention Not Available completed NCT03503318
Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia treatment 3 completed NCT00006418
Molecular Genetics of Schizophrenia No drug interventions Not Available Not Available completed NCT01477918
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea No drug interventions Not Available Not Available unknown_status NCT05660018
TMS Related Biomarker Assessments No drug interventions other Not Available recruiting NCT02161718
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder treatment 2 completed NCT04093518
Estradiol as add-on to Antipsychotics treatment 3 unknown_status NCT00495118
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. No drug interventions treatment 3 completed NCT02322918
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder No drug interventions Not Available Not Available unknown_status NCT02134418
Evaluation of Social Skills Intervention on Cognitive Function in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT00827918
A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004) No drug interventions treatment 2 completed NCT05328518
Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients. No drug interventions Not Available Not Available recruiting NCT00501618
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder No drug interventions basic_science 4 completed NCT01822418
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) treatment 4 completed NCT00218218
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia basic_science 2 completed NCT02378818
Characterization of the Motivational Deficit in Schizophrenia and Depression No drug interventions basic_science Not Available unknown_status NCT05207319
Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia No drug interventions supportive_care Not Available completed NCT00155519
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions No drug interventions Not Available Not Available completed NCT01731119
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents treatment 2 completed NCT04294719
A Study of Cognitive Adaptation Training in Inpatient Forensic Environments No drug interventions Not Available Not Available completed NCT02360319
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics health_services_research 4 completed NCT01943019
Linagliptin in Schizophrenia Patients treatment 1 terminated NCT00269919
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia treatment 4 completed NCT01381419
First Time in Human Study (FTIH) With Positron Emission Tomography (PET) No drug interventions treatment 1 completed NCT02853019
Emotion and Motivation in Patients With Psychosis No drug interventions other Not Available recruiting NCT00659919
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone No drug interventions treatment 4 completed NCT01452919
A Physical Dependence Study in Schizophrenia treatment 3 completed NCT04115319
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. treatment 3 completed NCT00611741
The Effect of Plasma Osmolality on Brain Glutamate No drug interventions Not Available 1 completed NCT01549041
Once-Daily Asenapine for Schizophrenia treatment 4 completed NCT03370341
Stimulating the Brain to Improve Self-Awareness No drug interventions basic_science Not Available completed NCT05473741
Risk of Breakthrough Symptoms With Long-Acting Injectable Medications Not Available Not Available recruiting NCT01512641
Prevalence of Dissociative Disorders in Children No drug interventions diagnostic Not Available completed NCT02823041
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode No drug interventions treatment Not Available completed NCT03523741
Therapeutic Drug Monitoring for Individualized Clozapine Therapy Not Available Not Available unknown_status NCT00078741
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness No drug interventions treatment 2 completed NCT05779241
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 treatment 3 completed NCT00447941
Safety, PK and PD Study in Healthy Male Japanese Subjects No drug interventions treatment 1 completed NCT06199817
The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia No drug interventions supportive_care Not Available completed NCT01886417
Auditory Verbal Hallucinations in Schizophrenia No drug interventions Not Available Not Available completed NCT01123317
Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia basic_science Not Available withdrawn NCT02366117
Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems No drug interventions Not Available Not Available unknown_status NCT00167817
Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study treatment 4 completed NCT02237417
Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism treatment 4 completed NCT01915017
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT03261817
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders No drug interventions supportive_care Not Available terminated NCT05824117
Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education. No drug interventions treatment Not Available recruiting NCT01072617
Cerebellar rTMS for the Treatment of Schizophrenic Patients No drug interventions treatment Not Available completed NCT00283517
A Registry of Treatment Adherence for Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04481217
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia No drug interventions basic_science Not Available unknown_status NCT02442817
Linagliptin and Mesenchymal Stem Cells: A Pilot Study basic_science 4 completed NCT02110017
Exploration of Neural Bases in Social Cognition No drug interventions health_services_research Not Available unknown_status NCT04248517
Using mHealth to Optimize Pharmacotherapy Regimens No drug interventions other Not Available completed NCT00101634
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia treatment 3 completed NCT02667834
Efficiency of the French Translation Social Cognition and Interactive Training (SCIT)Program No drug interventions treatment Not Available completed NCT03451734
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients Not Available Not Available completed NCT02869334
Remediation of Auditory Recognition in Schizophrenia With tDCS No drug interventions treatment Not Available completed NCT01243034
Waist Circumference Measurements in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT01746134
The Management of Schizophrenia in Clinical Practice (MOSAIC) No drug interventions Not Available Not Available completed NCT00167934
Determining Metabolic Effects of Valproate and Antipsychotic Therapy treatment Not Available completed NCT04712734
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia treatment 1 completed NCT00473434
An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia No drug interventions treatment 3 completed NCT04446234
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building treatment 4 unknown_status NCT00637234
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia No drug interventions treatment 2 / 3 completed NCT00439634
Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia No drug interventions treatment 2 terminated NCT03079024
Minnesota Community-Based Cognitive Training in Early Psychosis No drug interventions treatment Not Available completed NCT01567124
Alleviating the Metabolic Side Effects of Antipsychotic Medications treatment 4 withdrawn NCT04709224
Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia treatment 1 completed NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates treatment 4 recruiting NCT04637724
Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia No drug interventions treatment Not Available completed NCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone treatment 3 completed NCT06494124
Efficacy and Safety of tACS vs tDCS in Schizophrenia No drug interventions treatment Not Available recruiting NCT02520024
Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living No drug interventions Not Available Not Available completed NCT01213524
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia basic_science 2 completed NCT00042224
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia treatment 1 / 2 completed NCT02167724
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or No drug interventions Not Available Not Available completed NCT01948024
Bio-equivalence Study Between SAPHRIS and Asenapine other 1 completed NCT01607424
Specific Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT01793324
EMR Data to Assess Monitoring of Patients Treated With Quetiapine No drug interventions Not Available Not Available completed NCT01268124
Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects No drug interventions treatment 1 completed NCT02458924
Niacin Skin Flush Response in Patients With Schizophrenia diagnostic 2 / 3 completed NCT01698216
Switching From Consta® to Sustenna® in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT01423916
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder treatment 1 completed NCT00490516
ACP-104 in Acutely Psychotic Subjects With Schizophrenia No drug interventions treatment 2 completed NCT01568216
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms No drug interventions treatment 2 terminated NCT00261716
Motivational Interviewing to Improve Work Outcomes in Schizophrenia No drug interventions treatment 3 completed NCT00885716
A Shared Decision Making Training for Inpatients With Schizophrenia No drug interventions health_services_research Not Available unknown_status NCT00307216
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis No drug interventions treatment Not Available completed NCT03602716
High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia No drug interventions treatment Not Available terminated NCT03822416
Treating Smokers With Mental Illness treatment 2 completed NCT04432116
Time and Virtual Reality in Schizophrenia and Bipolar Disorder No drug interventions basic_science Not Available unknown_status NCT04004416
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis basic_science 4 recruiting NCT01998516
Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder No drug interventions Not Available Not Available completed NCT02131116
Integrated Metacognitive Therapy in First Episode Psychosis No drug interventions treatment Not Available completed NCT00937716
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies No drug interventions Not Available Not Available completed NCT01563016
Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT06336616
Getting Out of the House: Using Behavioral Activation to Increase Community Participation No drug interventions supportive_care Not Available recruiting NCT04335916
Survey on Pre-ECT Evaluation and ECT Application No drug interventions Not Available Not Available unknown_status NCT03818516
Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia No drug interventions basic_science Not Available completed NCT05643196
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia No drug interventions treatment 2 recruiting NCT00237796
Functional Rehabilitation of Older Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01028196
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression No drug interventions Not Available Not Available completed NCT00541996
Study Comparing Bioavailability of Oral Formulations of Vabicaserin No drug interventions health_services_research 1 completed NCT04399096
Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations No drug interventions Not Available Not Available unknown_status NCT01142596
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) treatment 3 completed NCT04240496
Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics No drug interventions supportive_care Not Available completed NCT01377896
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours No drug interventions Not Available Not Available completed NCT00564096
Transcranial Magnetic Stimulation (TMS) in Schizophrenia No drug interventions basic_science 2 / 3 unknown_status NCT04870996
RCT of tDCS Combined With Cognitive Training in Schizophrenia No drug interventions basic_science Not Available completed NCT01376596
Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia No drug interventions treatment 1 / 2 completed NCT00814996
Social Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT06284096
The Personal Recovery Based Psychoeducation For Schizophrenia No drug interventions supportive_care Not Available not_yet_recruiting NCT02552758
The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism treatment Not Available unknown_status NCT00005658
Glycine to Treat Psychotic Disorders in Children treatment 2 completed NCT00154258
A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia treatment 2 completed NCT06071858
Enhanced Coordinated Specialty Care for Early Psychosis No drug interventions treatment Not Available recruiting NCT05416658
Shared Decision Making for Antipsychotic Medications No drug interventions health_services_research Not Available not_yet_recruiting NCT01125358
A Study in Schizophrenic Patients treatment 2 terminated NCT02669758
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia No drug interventions treatment 3 completed NCT02593058
Positive Emotions Program for Schizophrenia (PEPS) No drug interventions treatment Not Available completed NCT00697658
INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT05368558
Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia treatment 3 active_not_recruiting NCT01683058
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia treatment 3 completed NCT01368458
Conversion to Antipsychotic Monotherapy No drug interventions treatment Not Available terminated NCT05137158
iTBS on Negative Symptoms and Cognitive Function in Schizophrenia No drug interventions treatment Not Available completed NCT01716858
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00231335
Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia treatment 4 completed NCT02090335
Health Promotion and Fitness for Younger and Older Adults With SMI No drug interventions prevention Not Available completed NCT04553835
Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients No drug interventions treatment Not Available unknown_status NCT04655235
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting NCT04865835
A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. treatment 1 completed NCT04176835
Oxytocin and Social Decision Making in Schizophrenia other Not Available completed NCT03959735
High Intensity Interval Training in Severe Mental Illness No drug interventions treatment Not Available completed NCT01774435
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant No drug interventions treatment 1 completed NCT00057135
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness No drug interventions treatment Not Available completed NCT00223535
Cognitive Remediation and Social Skills Training in Schizophrenia No drug interventions treatment Not Available completed NCT04975035
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine No drug interventions treatment 1 / 2 terminated NCT01793935
Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia No drug interventions treatment Not Available completed NCT02237235
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia No drug interventions treatment 2 completed NCT00690235
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia No drug interventions other 4 completed NCT01726335
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia treatment 4 completed NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia treatment 3 recruiting NCT01175135
An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia treatment 2 completed NCT04148963
A Study of Staccato Loxapine (ADASUVE®) for Inhalation treatment 3 unknown_status NCT00570063
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo No drug interventions treatment 2 terminated NCT02227563
tDCS & Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available terminated NCT01602263
Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing No drug interventions Not Available Not Available completed NCT01499563
Study of a Novel Antipsychotic ITI-007 in Schizophrenia treatment 2 completed NCT02712463
A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics No drug interventions Not Available Not Available completed NCT02534363
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up treatment 4 completed NCT06345963
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) No drug interventions treatment Not Available recruiting NCT00455663
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia No drug interventions treatment Not Available completed NCT00102063
Aripiprazole in Adolescents With Schizophrenia treatment 3 completed NCT01031563
Risk Perception in Drug-Dependent Adults With and Without Schizophrenia No drug interventions Not Available Not Available completed NCT05032963
Neurocognition After Perturbed Sleep No drug interventions basic_science Not Available completed NCT05464563
Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in Schizophrenia No drug interventions other Not Available completed NCT04511663
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients No drug interventions treatment Not Available completed NCT03497663
VIA Family - Family Based Early Intervention Versus Treatment as Usual No drug interventions treatment Not Available completed NCT06155786
Cognitive Effects of tDCS and tRNS in Schizophrenia No drug interventions treatment Not Available recruiting NCT00001486
Genetic Study of Schizophrenia No drug interventions Not Available Not Available recruiting NCT01397786
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia treatment 3 completed NCT04092686
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia treatment 3 completed NCT02532686
DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia No drug interventions treatment 2 completed NCT05413486
Sleep, Obesity and Mental Disease - Biological Markers for the Evaluation of Circadian Rhythmicity No drug interventions Not Available Not Available recruiting NCT02748486
Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... No drug interventions treatment Not Available completed NCT05282186
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia No drug interventions treatment Not Available recruiting NCT00712686
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia No drug interventions treatment 3 completed NCT01088386
Zyprexa® Relprevv™ Patient Care Program No drug interventions Not Available Not Available enrolling_by_invitation NCT02197286
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia treatment 2 withdrawn NCT03121586
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia treatment 3 terminated NCT06060886
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis treatment 4 not_yet_recruiting NCT03527186
Comparative Bioavailability of Risperidone treatment 1 completed NCT02614586
Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia other 1 terminated NCT03865186
An Evaluation of a Psychoeducation Program in Individuals Diagnosed With Schizophrenia No drug interventions supportive_care Not Available completed NCT00655239
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis No drug interventions prevention Not Available completed NCT00369239
Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis No drug interventions treatment 4 completed NCT01773239
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia No drug interventions treatment Not Available completed NCT00295139
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients No drug interventions treatment Not Available completed NCT03485339
Substance Misuse To Psychosis for Ketamine (SToP-K) No drug interventions Not Available Not Available completed NCT04278339
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder No drug interventions other Not Available recruiting NCT03382639
A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia other 2 completed NCT00169039
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia treatment 4 terminated NCT01683539
Understanding How Cognitive Remediation Works No drug interventions treatment Not Available completed NCT02337439
Perceptual Deficits in Schizophrenia No drug interventions treatment Not Available unknown_status NCT01466439
Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component No drug interventions basic_science 2 completed NCT01786239
Omega-3 Dietary Supplements in Schizophrenia treatment Not Available completed NCT01362439
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years treatment 4 completed NCT00352339
The New Strategy for Pharmacological Treatment in People With Schizophrenia No drug interventions treatment 4 unknown_status NCT02884739
Mental Healthcare in Older Adults With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03873922
Ketogenic Diet for Psychotic Disorders No drug interventions treatment Not Available recruiting NCT02681822
Multi-center Imaging Genetics Studies in China No drug interventions Not Available Not Available unknown_status NCT01579422
Social Cognitive Training for Psychosis: Treatment Development No drug interventions treatment 1 completed NCT01879722
Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants treatment 1 completed NCT02787122
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00977522
A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia treatment 2 terminated NCT00224822
The Effects of Aripiprazole on Patients With Metabolic Syndrome treatment 4 completed NCT02892422
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia No drug interventions treatment 3 completed NCT00305422
Effect of Quetiapine on Negative Symptoms and Cognition No drug interventions treatment 3 completed NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment No drug interventions Not Available Not Available unknown_status NCT01900522
Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia Not Available 1 terminated NCT00166322
Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects No drug interventions diagnostic Not Available completed NCT00024622
PET Scanning in Parkinson s Disease No drug interventions Not Available Not Available recruiting NCT03996122
Research of Anatomo-functional Biomarkers in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02013622
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia treatment 3 completed NCT01493622
The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia treatment 4 completed NCT00239122
Recovery Therapy Trial No drug interventions treatment Not Available completed NCT00538122
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment No drug interventions Not Available Not Available completed NCT01875822
Open-label Study of Curcumin C-3 Complex in Schizophrenia No drug interventions treatment 1 / 2 completed NCT01884025
Get Moving and Get Well - Pilot Study No drug interventions treatment Not Available completed NCT05838625
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT03922425
Community-based Mental Health Care for People With Severe and Enduring Mental III Health No drug interventions supportive_care Not Available unknown_status NCT05179525
Comparative Bioavailability of Risperidone. treatment 1 completed NCT00194025
Valproate in Late Life Schizophrenia treatment 4 completed NCT03510325
Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime treatment 4 unknown_status NCT03662425
Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible Mechanisms treatment Not Available completed NCT06474325
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA No drug interventions supportive_care Not Available not_yet_recruiting NCT01139125
An Open Trial of Cysteamine Treatment in Schizophrenia treatment Not Available terminated NCT03893825
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia treatment 3 completed NCT00580125
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia No drug interventions treatment 2 completed NCT02918825
Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia treatment Not Available completed NCT02935725
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males treatment 1 completed NCT00205725
Pfizer/IVGTT/Ziprasidone/Olanzapine treatment Not Available completed NCT03451630
PCORI Integrated Care (IC) Models for Patient-Centered Outcomes No drug interventions health_services_research Not Available active_not_recruiting NCT02717130
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol treatment Not Available terminated NCT01012830
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia treatment 4 unknown_status NCT04370730
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents No drug interventions other Not Available recruiting NCT02224430
Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors No drug interventions Not Available Not Available completed NCT00914030
Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders No drug interventions Not Available Not Available unknown_status NCT04414930
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia No drug interventions treatment 2 recruiting NCT02526030
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up treatment 4 completed NCT00448630
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics No drug interventions Not Available Not Available completed NCT01523730
Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia No drug interventions basic_science Not Available completed NCT00758030
Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults. No drug interventions treatment 1 completed NCT05448430
iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging. No drug interventions screening Not Available unknown_status NCT02675530
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism Not Available 1 completed NCT05111548
Brain Stimulation and Cognitive Training - Efficacy No drug interventions treatment Not Available completed NCT01245348
Relative Effectiveness of Schizophrenia Therapy Study No drug interventions Not Available Not Available completed NCT01942148
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia treatment 3 completed NCT05899348
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders No drug interventions treatment Not Available recruiting NCT05567848
Accelerated TMS in Psychosis No drug interventions treatment 1 / 2 enrolling_by_invitation NCT01939548
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia treatment 2 terminated NCT01150448
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia treatment 1 completed NCT00085748
Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia treatment 3 completed NCT00295048
Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT02685748
Aspirin in Young Psychotic Patients treatment 2 / 3 completed NCT02622048
Understanding and Helping Families: Parents With Psychosis No drug interventions supportive_care Not Available unknown_status NCT05345548
Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives. No drug interventions diagnostic Not Available unknown_status NCT01086748
A Study in Schizophrenia Patients treatment 2 completed NCT00575848
Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia No drug interventions basic_science 1 terminated NCT06347848
The Effect of Psychoeducation Focused on Reducing Internalized Stigma No drug interventions supportive_care Not Available not_yet_recruiting NCT06197048
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder No drug interventions prevention Not Available recruiting NCT00210548
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia No drug interventions treatment 3 completed NCT05784948
Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis No drug interventions prevention Not Available completed NCT00946348
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment No drug interventions basic_science 1 completed NCT05340348
Patientheque in Patients With a Psychosis . No drug interventions basic_science Not Available recruiting NCT06486948
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment With CT-156 for People With Schizophrenia. No drug interventions basic_science Not Available active_not_recruiting NCT04068857
Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP) No drug interventions treatment Not Available withdrawn NCT03260257
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia No drug interventions treatment Not Available completed NCT00161057
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment No drug interventions Not Available Not Available completed NCT04436757
Self and Body-esteem in Socio-professional Rehabilitation No drug interventions treatment Not Available unknown_status NCT03201757
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 No drug interventions treatment 3 completed NCT04210557
Models of Auditory Hallucination No drug interventions basic_science Not Available terminated NCT00508157
A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome No drug interventions treatment 4 terminated NCT04856657
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing No drug interventions Not Available Not Available completed NCT04038957
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging treatment 1 completed NCT06572657
Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial No drug interventions treatment Not Available recruiting NCT01410357
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes No drug interventions supportive_care Not Available completed NCT03730857
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics treatment 1 completed NCT03217357
tDCS, Stress and Risk for Schizophrenia No drug interventions basic_science Not Available completed NCT03075657
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia treatment 4 completed NCT02566057
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis No drug interventions treatment Not Available completed NCT03393026
A Study of Lurasidone HCl in Subjects With Schizophrenia treatment 4 completed NCT01493726
A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia treatment 1 completed NCT04143126
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES) No drug interventions treatment Not Available recruiting NCT02202226
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia No drug interventions treatment 1 completed NCT01046526
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia No drug interventions Not Available Not Available completed NCT00330226
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders No drug interventions Not Available Not Available unknown_status NCT03601026
Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use No drug interventions prevention Not Available recruiting NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine other 4 terminated NCT02009826
Psychosis-Associated Neuroinflammation in Schizophrenia No drug interventions Not Available Not Available completed NCT00768326
Efficacy of Lu 31-130 in Patients With Schizophrenia No drug interventions treatment 2 completed NCT01547026
Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients No drug interventions treatment Not Available completed NCT01521026
Cognitive Training for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT04849026
Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18 basic_science 1 completed NCT00445926
Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia No drug interventions treatment 1 completed NCT00334126
Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT03559426
Research Into Antipsychotic Discontinuation and Reduction Trial No drug interventions treatment 4 completed NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Not Available Not Available completed NCT00981526
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia treatment 4 completed NCT04916626
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis No drug interventions treatment Not Available recruiting NCT00373126
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia No drug interventions treatment 4 completed NCT00400166
Recovery Guide Intervention for Recurrent Psychiatric Hospitalization No drug interventions supportive_care Not Available completed NCT04418466
Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant treatment 1 / 2 completed NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome treatment Not Available completed NCT00575666
Intranasal Insulin Treatment in Patients With Schizophrenia No drug interventions treatment 4 completed NCT01369966
Brain Circuits in Schizophrenia and Smoking No drug interventions Not Available Not Available completed NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT04323566
Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement treatment 2 enrolling_by_invitation NCT01412866
Electronic Decision Support Systems for Smokers With Severe Mental Illness No drug interventions treatment Not Available completed NCT06556966
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects No drug interventions treatment 1 not_yet_recruiting NCT00169065
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia treatment 4 completed NCT01093365
Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia treatment 2 completed NCT00505765
A Multicenter Study of NAP (AL-108) in Schizophrenia No drug interventions treatment 2 completed NCT03663465
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics No drug interventions prevention Not Available completed NCT05109065
Peripheral Immune System in Individuals With Schizophrenia No drug interventions Not Available Not Available recruiting NCT02746965
Magnetic Seizure Therapy for Schizophrenia No drug interventions treatment Not Available terminated NCT03130465
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02756065
Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia No drug interventions Not Available Not Available completed NCT02896374
Normal and Abnormal ERP During ToM and Emotional Conflicts in Schizophrenia No drug interventions diagnostic Not Available completed NCT00235274
Effects of RG1068 (Secretin) on Information Processing in Schizophrenia treatment 2 completed NCT04659174
An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) treatment 3 completed NCT03005574
Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program No drug interventions treatment Not Available completed NCT01855074
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders treatment 4 completed NCT00000374
Treatment for First-Episode Schizophrenia treatment 4 completed NCT00305474
Identification and Treatment of the Liability to Develop Schizophrenia No drug interventions diagnostic 4 unknown_status NCT01788774
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths treatment 1 completed NCT02034474
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia treatment 4 completed NCT03621774
Mobile CBT for Negative Symptoms No drug interventions treatment Not Available completed NCT00245674
SOLIACS: Solian Solution in the Acute Setting treatment 4 completed NCT00535574
Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia No drug interventions prevention 3 completed NCT03652974
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy treatment 4 completed NCT01593774
Melatonin for Prevention of Metabolic Side Effects of Olanzapine prevention 2 completed NCT00237874
Aripiprazole Treatment of Prodromal Patients treatment 2 / 3 completed NCT04874974
Feasibility of a Novel Process-based Treatment for Patients With Psychosis No drug interventions treatment Not Available completed NCT01140620
Effects of Ketamine and Risperidone on Cognition basic_science 4 completed NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder treatment 3 completed NCT01045720
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia No drug interventions treatment 2 unknown_status NCT00628420
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics No drug interventions Not Available 1 completed NCT01235520
A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) treatment 3 completed NCT01448720
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate treatment 3 completed NCT00783120
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT00527020
First Time in Human Study With GSK1018921 No drug interventions treatment 1 completed NCT01342120
PHARMO Institute Seroquel Safety Study No drug interventions Not Available Not Available completed NCT03995420
VR Therapy for Psychosis Negative Symptoms (V-NeST) No drug interventions treatment Not Available unknown_status NCT03522220
Augmentation of Neuronal Network Plasticity in Schizophrenia No drug interventions basic_science Not Available unknown_status NCT01258920
A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia treatment 3 completed NCT06573320
Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine No drug interventions treatment Not Available recruiting NCT03974620
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT00137020
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder treatment 4 completed NCT00465920
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis No drug interventions treatment 2 unknown_status NCT00412620
An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia No drug interventions treatment 2 terminated NCT02167620
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness treatment 4 completed NCT00982020
Study in Adolescents With Schizophrenia or Bipolar Disorder treatment 4 completed NCT02713282
A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation treatment 3 completed NCT01320982
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 unknown_status NCT01129882
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia treatment 3 completed NCT02033382
Biomarkers in First Episode Schizophrenia No drug interventions Not Available Not Available completed NCT00192582
AIMHI NT Relapse Prevention Trial No drug interventions Not Available Not Available unknown_status NCT01942382
A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia treatment 1 completed NCT02969382
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia treatment 2 completed NCT02874482
Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00265382
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia No drug interventions treatment 3 terminated NCT03418831
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women treatment 4 completed NCT03967431
Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia No drug interventions other Not Available completed NCT00809731
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment No drug interventions Not Available Not Available completed NCT03485131
Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations No drug interventions treatment Not Available completed NCT01685931
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics treatment 4 completed NCT01828931
Lifestyle Intervention for Diabetes and Weight Management in Psychosis No drug interventions treatment Not Available completed NCT02341131
Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels No drug interventions treatment Not Available completed NCT00161031
Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia treatment Not Available completed NCT04798131
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations No drug interventions treatment Not Available not_yet_recruiting NCT03859973
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia treatment 2 completed NCT01971073
Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia No drug interventions treatment Not Available terminated NCT03892473
Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E ) No drug interventions health_services_research Not Available unknown_status NCT00505973
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects No drug interventions treatment 1 completed NCT01324973
Web-Based Weight Management for Individuals With Mental Illness No drug interventions treatment Not Available completed NCT02874573
Tocilizumab in Schizophrenia treatment 1 recruiting NCT00418873
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward No drug interventions treatment 4 terminated NCT03476473
Early Detection of Respiratory Disorders in Psychosis No drug interventions Not Available Not Available unknown_status NCT01994473
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia treatment 1 completed NCT05838573
Metformin Treatment on Cognitive Impairment of Schizophrenia treatment 3 recruiting NCT01309373
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04054973
L-arginine Study for Persistent Symptoms of Schizophrenia treatment 2 withdrawn NCT01074073
Lithium Drug-Drug Interaction Study With Lurasidone HCl Not Available 1 completed NCT01634373
Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Not Available 1 completed NCT01182727
Salsalate for Insulin Resistance in Schizophrenia treatment Not Available completed NCT00366327
Study Evaluating Bifeprunox in Patients With Schizophrenia. No drug interventions treatment 3 terminated NCT00314327
Optimizing Response in Psychosis Study No drug interventions treatment 4 terminated NCT00797927
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia No drug interventions treatment 4 completed NCT00103727
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia treatment 2 completed NCT03774927
High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients No drug interventions treatment Not Available completed NCT03880227
Improving Visual Attention in Schizophrenia No drug interventions basic_science Not Available completed NCT04118127
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses No drug interventions treatment 1 completed NCT00080327
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia treatment 4 completed NCT05342727
Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia No drug interventions basic_science 1 completed NCT00838227
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder No drug interventions treatment 2 withdrawn NCT02478827
A Trial of Cognitive Training in Schizophrenia No drug interventions supportive_care Not Available completed NCT01913327
Antipsychotic Effects on Brain Function in Schizophrenia treatment 4 terminated NCT05956327
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training No drug interventions supportive_care Not Available recruiting NCT00505076
Treatment Study for Cognitive Deficits in Schizophrenia No drug interventions treatment 2 completed NCT01927276
Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive No drug interventions other Not Available completed NCT00216476
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT00654576
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia No drug interventions treatment 4 completed NCT00224276
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics No drug interventions Not Available Not Available completed NCT03892876
Trial of Stimulus-response Potentiation in Schizophrenia No drug interventions treatment Not Available completed NCT02926976
The Optimal Treatment for Treatment-resistant Schizophrenia treatment Not Available unknown_status NCT03576976
Improving Accessibility and Personalization of CR for Schizophrenia No drug interventions treatment Not Available completed NCT00796276
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone No drug interventions treatment 1 completed NCT01376076
Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia treatment 1 completed NCT03164876
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers. treatment 1 completed NCT00100776
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT00924976
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families No drug interventions health_services_research Not Available completed NCT02864576
Cognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment No drug interventions treatment Not Available completed NCT02535676
Schizophrenia TreAtment With electRic Transcranial Stimulation No drug interventions treatment 3 completed NCT00205660
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole No drug interventions treatment 4 completed NCT04187560
Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults treatment 1 completed NCT00001260
Brain Tissue Collection for Neuropathological Studies No drug interventions Not Available Not Available terminated NCT01577160
A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia treatment 4 completed NCT01620060
Lurasidone Pediatric Pharmacokinetics Study treatment 1 completed NCT00533260
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) No drug interventions Not Available Not Available completed NCT05951660
Sex, Psychopharmacology, and Diabetes No drug interventions supportive_care Not Available recruiting NCT04825860
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase treatment 2 / 3 terminated NCT01009060
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia treatment 2 completed NCT00712660
Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia No drug interventions prevention Not Available completed NCT00759460
Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00430560
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia No drug interventions treatment 2 / 3 completed NCT01412060
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia prevention 3 completed NCT05517460
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center No drug interventions supportive_care Not Available completed NCT00940394
Effectiveness of Family Group Interventions for People With Schizophrenia No drug interventions health_services_research 2 completed NCT00136994
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) treatment 3 completed NCT02570594
Autobiographical Memory Organization in Schizophrenia No drug interventions diagnostic Not Available completed NCT05119894
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia treatment 1 withdrawn NCT02863094
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations No drug interventions treatment Not Available completed NCT00182494
Diabetes Prevention Program in Schizophrenia [DPPS] No drug interventions prevention 4 unknown_status NCT03693794
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics No drug interventions Not Available Not Available unknown_status NCT00261794
Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT04005794
Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training No drug interventions basic_science Not Available recruiting NCT00246194
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) Not Available Not Available completed NCT00105794
Psychiatric Advance Directives for Improved Mental Health Care No drug interventions treatment Not Available completed NCT01518894
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia basic_science 1 completed NCT05746494
The Efficacy of Neural Stimulation in Individuals With Schizophrenia No drug interventions basic_science Not Available active_not_recruiting NCT00231894
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia treatment 4 completed NCT02748694
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study No drug interventions other 1 completed NCT03919994
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) No drug interventions Not Available Not Available completed NCT00222794
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia treatment 4 completed NCT04545294
Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT05664594
State Representation in Early Psychosis - Project 4 No drug interventions basic_science Not Available recruiting NCT00957294
Metabolic Syndrome in Patients With First-episode Schizophrenia No drug interventions Not Available Not Available completed NCT01165294
The Effect of Ketamine on Attentiveness basic_science 1 completed NCT00113594
Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder treatment 3 completed NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents treatment 4 recruiting NCT01370291
Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients No drug interventions treatment 3 unknown_status NCT02782091
Discriminant Validity of the Multiple Errands Test in Schizophrenia No drug interventions diagnostic Not Available completed NCT02532491
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up treatment 4 unknown_status NCT00430391
Comparison of Video Consent Versus Routine Consent for Participation in Research Studies No drug interventions Not Available Not Available completed NCT03346291
Examining Persistence in Smokers With Schizophrenia No drug interventions treatment Not Available completed NCT01401491
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine treatment 4 completed NCT02670291
Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation No drug interventions treatment Not Available completed NCT00210691
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT02006862
eVAluatIon of OLanzapine TreatmEnT No drug interventions Not Available Not Available completed NCT00312962
Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia No drug interventions treatment 1 / 2 completed NCT00211562
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids prevention 3 terminated NCT02022462
Project Bridge: Peer Health Navigator Intervention No drug interventions treatment Not Available completed NCT02210962
Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia No drug interventions prevention 4 unknown_status NCT00179062
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder treatment Not Available completed NCT00921362
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme No drug interventions Not Available Not Available completed NCT02281162
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain No drug interventions Not Available Not Available completed NCT02704962
Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine treatment 4 completed NCT06442462
Study of SPG302 in Adults With Schizophrenia treatment 2 recruiting NCT01655680
A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia treatment 2 completed NCT00137280
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) No drug interventions health_services_research Not Available completed NCT01810380
Brexpiprazole in Patients With Acute Schizophrenia treatment 3 completed NCT00177580
Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin treatment 4 completed NCT05582980
Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia No drug interventions treatment Not Available recruiting NCT01289080
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects treatment 1 completed NCT05304780
Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia No drug interventions supportive_care Not Available completed NCT01263080
Evaluation of Mirtazapine and Folic Acid for Schizophrenia: treatment 4 completed NCT02334280
Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI No drug interventions health_services_research Not Available completed NCT01192880
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia treatment 3 completed NCT00004980
Repetitive Transcranial Magnetic Stimulation for "Voices" No drug interventions treatment 2 completed NCT02765880
Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders No drug interventions other Not Available recruiting NCT00645580
Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function No drug interventions treatment Not Available unknown_status NCT04011280
Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness treatment 4 completed NCT00216580
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis No drug interventions treatment 3 completed NCT00211380
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) No drug interventions treatment Not Available terminated NCT02349880
A Shared Decision-making Training for Inpatients With Schizophrenia No drug interventions health_services_research Not Available completed NCT02131129
rTMS in First Episode Psychosis No drug interventions treatment Not Available completed NCT00364429
SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia No drug interventions diagnostic 1 terminated NCT01154829
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) diagnostic Not Available completed NCT05282329
Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia No drug interventions treatment Not Available completed NCT01078129
Cognitive Remediation Therapy and Schizophrenia No drug interventions supportive_care Not Available completed NCT00650429
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder No drug interventions treatment 4 completed NCT02642029
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study No drug interventions basic_science Not Available completed NCT01568229
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) No drug interventions treatment 2 terminated NCT01542229
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) No drug interventions health_services_research Not Available completed NCT01911429
Pediatric Schizophrenia Efficacy and Safety Study treatment 3 completed NCT00681629
Schizophrenic Patients in Integrated Care No drug interventions treatment 4 terminated NCT01488929
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia treatment 2 completed NCT01696929
An Open-Label Trial of Tocilizumab in Schizophrenia treatment 1 completed NCT02232529
Pharmacokinetic Study of MIN-101 in Healthy Subjects basic_science 1 completed NCT03314129
Remediation of Visual Perceptual Impairments in People With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT03558529
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse No drug interventions Not Available Not Available completed NCT00796029
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose No drug interventions treatment 1 completed NCT01794429
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue treatment 3 completed NCT00173329
The Quality of Life of Patients With Severe Illnesses No drug interventions Not Available Not Available unknown_status NCT02019329
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone treatment 1 completed NCT02077829
Implementation of Illness Management and Recovery in Mental Health Services No drug interventions health_services_research Not Available completed NCT00645229
A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder No drug interventions treatment 3 terminated NCT00761189
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia No drug interventions treatment 4 completed NCT02469389
Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT02326389
Exercise and Cognitive Training No drug interventions treatment Not Available completed NCT01082289
Digoxin Drug-Drug Interaction With Lurasidone HCl Not Available 1 completed NCT06356389
A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. No drug interventions treatment 1 / 2 completed NCT00325689
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. No drug interventions treatment 4 completed NCT05698589
COMpassion for Psychiatric Disorders And Self-Stigma No drug interventions treatment Not Available recruiting NCT01689389
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study No drug interventions Not Available Not Available completed NCT01170689
The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan No drug interventions Not Available Not Available completed NCT03469089
Touchscreen-based Cognitive Tests in Healthy Volunteers No drug interventions basic_science 1 unknown_status NCT00174889
Pregnenolone in the Management of Schizophrenia Patients treatment 1 completed NCT01760889
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia No drug interventions treatment 3 terminated NCT03892889
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® No drug interventions health_services_research 3 terminated NCT05065489
Resting State Electroencephalogram for Psychotic Disorders No drug interventions Not Available Not Available active_not_recruiting NCT00320489
Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia No drug interventions treatment 3 completed NCT01398189
F-18 Altanserin PET Study of Patients Receiving Clozapine No drug interventions basic_science Not Available unknown_status NCT00111189
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. prevention 3 completed NCT00061789
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia treatment 2 completed NCT02398292
A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis No drug interventions treatment Not Available completed NCT01364792
To Rescue Cognition With Valaciclovir No drug interventions treatment 2 completed NCT01041092
Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women No drug interventions treatment 4 completed NCT00257192
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia No drug interventions treatment 3 terminated NCT01376492
FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain No drug interventions Not Available Not Available completed NCT00790192
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. No drug interventions treatment 3 completed NCT04887792
Acetazolamide for Treatment Resistant Schizophrenia No drug interventions treatment 1 / 2 recruiting NCT00001192
Neuropsychological Evaluation of Psychiatric and Neurological Patients No drug interventions Not Available Not Available completed NCT02069392
Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia No drug interventions treatment Not Available completed NCT01104792
Long-term Study of Cariprazine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT05480592
A Study of HS-10380 in Chinese Participants No drug interventions treatment 1 recruiting NCT02885792
Coronary Artery Disease in Patients Suffering From Schizophrenia No drug interventions prevention Not Available unknown_status NCT00446992
Diabetes in Neuropsychiatric Disorders No drug interventions treatment 1 / 2 completed NCT05206292
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders. No drug interventions diagnostic Not Available recruiting NCT02008292
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors No drug interventions other Not Available completed NCT00140192
Creatine Treatment in Psychiatric Disorders prevention 3 completed NCT01908192
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® No drug interventions treatment 2 / 3 terminated NCT05739344
The Effect of Developing Psychological Resilience on Functionality in Schizophrenia Patients No drug interventions supportive_care Not Available completed NCT00480844
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone No drug interventions treatment 4 unknown_status NCT00044044
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia treatment 2 completed NCT00770744
Efficacy of Lu 31-130 in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00001544
Genetic Aspects of Neurologic and Psychiatric Disorders No drug interventions Not Available Not Available completed NCT02796144
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia No drug interventions treatment 4 terminated NCT04740944
Salutogenic Approach Based Interview With People With Schizophrenia No drug interventions health_services_research Not Available completed NCT02183844
A System for Preference Assessment in Mental Health No drug interventions health_services_research Not Available completed NCT02079844
Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia No drug interventions treatment 1 completed NCT00645944
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia No drug interventions treatment Not Available completed NCT03223844
Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release No drug interventions basic_science Not Available unknown_status NCT00499044
A Comparison of Two Cognitive Batteries in People With Schizophrenia No drug interventions Not Available Not Available completed NCT03351244
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months No drug interventions treatment 2 terminated NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs No drug interventions treatment 3 completed NCT04038840
Imaging Synapses With [11C] UCB-J in the Human Brain No drug interventions other 1 recruiting NCT00199940
Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness treatment 4 completed NCT00686140
A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia No drug interventions treatment Not Available completed NCT00791440
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy No drug interventions treatment Not Available completed NCT01429740
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults No drug interventions basic_science 1 completed NCT06326840
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment No drug interventions treatment Not Available completed NCT00827840
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia No drug interventions treatment 4 completed NCT03370640
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2). No drug interventions treatment 1 completed NCT04068467
Evaluation of mHealth for Serious Mental Illness No drug interventions supportive_care Not Available completed NCT01967667
Biological Evaluation of Dietary Supplement Liposomal Glutathione No drug interventions other Not Available completed NCT05304767
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT01192867
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) No drug interventions treatment 3 completed NCT00509067
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia No drug interventions treatment 2 completed NCT01029067
Metacognitive Training in Schizophrenia No drug interventions treatment Not Available completed NCT04280367
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age No drug interventions Not Available Not Available completed NCT00810667
Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia No drug interventions treatment 2 completed NCT01490567
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia No drug interventions treatment 4 unknown_status NCT00137267
A Brief Community Linkage Intervention for Dually Diagnosed Individuals No drug interventions prevention Not Available completed NCT01125267
Promoting Adherence to Treatment in Schizophrenia No drug interventions treatment Not Available completed NCT01546467
Cognitive Remediation in Early Phase Psychosis No drug interventions treatment Not Available unknown_status NCT02512367
Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia. No drug interventions other Not Available terminated NCT04158167
Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study No drug interventions other Not Available completed NCT02758067
Comparison of the Effectiveness of Brexpiprazole With That of Risperidone No drug interventions treatment 3 withdrawn NCT02897167
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients No drug interventions Not Available Not Available completed NCT02620267
Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS) No drug interventions device_feasibility Not Available completed NCT01012167
Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia No drug interventions treatment 2 completed NCT00485901
Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00155701
Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia No drug interventions Not Available Not Available completed NCT00409201
Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia No drug interventions treatment 1 unknown_status NCT02159001
Electroconvulsive Therapy in Clozapine-resistant Schizophrenia No drug interventions treatment Not Available unknown_status NCT00686101
Knowledge and Perception of Smoking Risks/Consequences No drug interventions Not Available Not Available completed NCT01011101
Internal Monitoring of Eye Movement in Schizophrenia No drug interventions Not Available Not Available terminated NCT02573701
Guideline vs Usual Treatment in Schizophrenic Adolescents No drug interventions treatment Not Available completed NCT03699501
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia No drug interventions Not Available Not Available completed NCT00791401
A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function No drug interventions treatment 1 completed NCT05809401
Pragmatic Assessment and Treatment for the Health System No drug interventions treatment Not Available recruiting NCT02832401
The Impact of Caffeine on Cognition in Schizophrenia No drug interventions basic_science Not Available completed NCT00034801
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia treatment 4 completed NCT01394601
A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia No drug interventions Not Available Not Available completed NCT00014001
CATIE- Schizophrenia Trial treatment 4 completed NCT00156104
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) treatment 3 completed NCT04296604
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations No drug interventions treatment Not Available recruiting NCT04190004
Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia No drug interventions other Not Available completed NCT00071604
Medication Adherence in Older People With Psychosis No drug interventions Not Available Not Available unknown_status NCT00569504
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics No drug interventions Not Available Not Available unknown_status NCT04767204
The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation Program No drug interventions health_services_research Not Available completed NCT01964404
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? No drug interventions basic_science 1 completed NCT05115604
Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention No drug interventions treatment Not Available completed NCT02199704
Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series No drug interventions Not Available Not Available completed NCT02882204
Tracking Outcomes in Psychosis No drug interventions Not Available Not Available unknown_status NCT00595504
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia No drug interventions treatment 4 completed NCT00876304
Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia No drug interventions basic_science 1 completed NCT00525304
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition No drug interventions supportive_care Not Available completed NCT02220504
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals No drug interventions treatment Not Available completed NCT00845572
The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center No drug interventions treatment Not Available completed NCT01729572
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients No drug interventions treatment Not Available unknown_status NCT04986072
Sodium Nitroprusside in Early Course Schizophrenia No drug interventions treatment 2 terminated NCT06315972
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity No drug interventions treatment 2 not_yet_recruiting NCT00463372
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT04173572
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial No drug interventions treatment Not Available completed NCT00559572
Effects of Motivating People With Schizophrenia to Exercise No drug interventions treatment Not Available completed NCT01136772
A Comparison of Long-acting Injectable Medications for Schizophrenia No drug interventions treatment 4 completed NCT01639872
Clozapine for Cannabis Use in Schizophrenia No drug interventions treatment 4 completed NCT00373672
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 4 completed NCT01552772
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole No drug interventions treatment 1 completed NCT01295372
Safety and Efficacy of Zicronapine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT05109572
The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center No drug interventions Not Available Not Available completed NCT01570972
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis No drug interventions treatment Not Available completed NCT03995368
Neuroplasticity in TBI and Schizophrenia No drug interventions basic_science Not Available completed NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics No drug interventions treatment Not Available completed NCT05352568
Is Cognitive Training an Option? No drug interventions treatment Not Available completed NCT04521868
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients No drug interventions treatment 2 completed NCT01764568
Contrasting Group Therapy Methods for Psychosis No drug interventions treatment Not Available terminated NCT03197168
Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile No drug interventions health_services_research Not Available completed NCT01036568
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia No drug interventions Not Available Not Available completed NCT00018668
Antipsychotic Response in Schizophrenia treatment 4 completed NCT03565068
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) No drug interventions treatment 1 completed NCT00208169
Abilify Therapy for Reducing Comorbid Substance Abuse treatment 4 completed NCT00838669
A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone No drug interventions treatment 1 completed NCT00173069
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) No drug interventions Not Available Not Available unknown_status NCT00264069
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry No drug interventions Not Available Not Available completed NCT03317769
Creating Live Interactions to Mitigate Barriers No drug interventions treatment Not Available completed NCT01081769
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics No drug interventions treatment 3 completed NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia No drug interventions treatment Not Available completed NCT04352569
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available recruiting NCT00642369
A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia No drug interventions treatment Not Available completed NCT03153046
The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis No drug interventions other Not Available completed NCT04306146
Study of CAD-9303 in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT02240446
Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients No drug interventions treatment Not Available withdrawn NCT01712646
Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia No drug interventions treatment 1 / 2 terminated NCT02449746
Study of Immunotherapy in Autoantibody Positive Psychosis No drug interventions other Not Available completed NCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography No drug interventions Not Available Not Available not_yet_recruiting NCT00419146
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants No drug interventions treatment 2 / 3 completed NCT06041646
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder No drug interventions treatment 4 completed NCT04300946
Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT00049946
Schizophrenia Study In Adults treatment 2 completed NCT00001246
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT06066112
Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body No drug interventions treatment 1 recruiting NCT05486312
7-week Study With CT-155 in People With Schizophrenia No drug interventions treatment Not Available completed NCT00090012
Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT03466112
Aerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute Schizophrenia No drug interventions other Not Available completed NCT04276012
Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA) No drug interventions treatment Not Available unknown_status NCT01926912
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting No drug interventions Not Available Not Available completed NCT01182012
Reduction of Cardiovascular Risk in Severe Mental Illness No drug interventions prevention 4 unknown_status NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder No drug interventions treatment 3 recruiting NCT00485810
Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia No drug interventions treatment 1 / 2 completed NCT01592110
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia No drug interventions treatment 1 completed NCT02174510
A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects No drug interventions basic_science 1 completed NCT00640510
A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia No drug interventions treatment 3 completed NCT00253110
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder No drug interventions treatment 4 completed NCT00736710
rTMS Effects on Smoking Cessation and Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT01662310
An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia No drug interventions treatment 3 completed NCT03434210
The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT02746510
Validation of a Clinical Screening Grid for Syndromic Schizophrenia No drug interventions diagnostic Not Available unknown_status NCT05724810
Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia No drug interventions treatment Not Available recruiting NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study No drug interventions Not Available Not Available completed NCT00567710
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study No drug interventions treatment 2 completed NCT03189810
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia No drug interventions treatment Not Available completed NCT00167310
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation treatment 2 completed NCT00329810
Effect on Cognitive Function of a Treatment With Aripiprazole No drug interventions treatment 4 completed NCT00331981
Amisulpride in Schizophrenic Patients No drug interventions treatment 4 completed NCT01860781
The Effect of Paliperidone Palmitate in Schizophrenia No drug interventions treatment 4 completed NCT02164981
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia No drug interventions treatment 2 completed NCT00646581
Effect of Single Dose Intranasal Insulin On Cognitive Function No drug interventions treatment 4 completed NCT01083381
Is MS14 Helpful in Schizophrenia? No drug interventions treatment 2 unknown_status NCT03649581
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders No drug interventions treatment Not Available recruiting NCT00315081
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine No drug interventions treatment 3 unknown_status NCT01001481
Schizophrenia Treatment Adherence Investigation (STAI) No drug interventions Not Available Not Available completed NCT01689181
Apathy in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02037581
Integrated Care Including Assertive Community Treatment in Early Psychosis No drug interventions treatment Not Available completed NCT02538081
Nicotinic Receptors and Schizophrenia No drug interventions treatment 1 / 2 withdrawn NCT00942981
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography No drug interventions Not Available Not Available recruiting NCT04055181
Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders No drug interventions treatment Not Available completed NCT00970281
A Study of Olanzapine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01474395
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia No drug interventions treatment 2 unknown_status NCT02411695
Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia No drug interventions treatment 1 completed NCT02717195
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia No drug interventions treatment 3 completed NCT03360695
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer No drug interventions supportive_care Not Available completed NCT01248195
Optimization of Treatment and Management of Schizophrenia in Europe No drug interventions treatment 4 completed NCT00500695
Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness No drug interventions treatment 1 completed NCT02880995
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis No drug interventions treatment Not Available unknown_status NCT00006195
Glucose Regulation During Risperidone and Olanzapine Treatment treatment Not Available unknown_status NCT03627195
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT03758495
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression No drug interventions Not Available Not Available withdrawn NCT00189995
Clozapine IM and Aggression in Schizophrenic Patients treatment 3 withdrawn NCT00605995
Add-on Simvastatin in Schizophrenia Trial No drug interventions treatment Not Available terminated NCT04990414
Cognitive Behaviour Therapy for Voices and Dissociation No drug interventions treatment 2 completed NCT00077714
Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia treatment 3 completed NCT00396214
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients No drug interventions treatment 3 terminated NCT00220714
PREvent First Episode Relapse (PREFER) No drug interventions treatment 4 unknown_status NCT01207414
Switching to Iloperidone From Other Antipsychotics in Schizophrenia No drug interventions treatment 4 completed NCT01044914
Genes, Intermediate Phenotypes and Response to Quetiapine RX No drug interventions Not Available Not Available completed NCT01769014
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder No drug interventions Not Available Not Available unknown_status NCT01555814
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen No drug interventions diagnostic Not Available completed NCT03695614
Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia No drug interventions treatment Not Available completed NCT03271814
Brain Biomarker on Inflammation Response No drug interventions basic_science 1 withdrawn NCT05731414
Outcomes From Remediation and Behavioural Intervention Techniques No drug interventions treatment Not Available recruiting NCT00132314
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia treatment 3 completed NCT04237155
French Source-monitoring Task No drug interventions other Not Available unknown_status NCT05746455
Motivation Skills Training for Schizophrenia No drug interventions treatment Not Available completed NCT04013555
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia No drug interventions other 1 / 2 recruiting NCT01813955
Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia No drug interventions health_services_research 0 terminated NCT02469155
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment No drug interventions treatment 3 completed NCT00304655
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) No drug interventions treatment 4 completed NCT00725855
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients No drug interventions treatment 2 unknown_status NCT05310955
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia No drug interventions treatment Not Available unknown_status NCT00929955
Role of Anti-Inflammatory Agents in Patients With Schizophrenia No drug interventions treatment 1 completed NCT01433055
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients No drug interventions treatment Not Available completed NCT01149655
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia No drug interventions treatment 3 completed NCT00716755
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. No drug interventions treatment Not Available completed NCT01251055
GlyT-1 Inhibitor Treatment for Refractory Schizophrenia No drug interventions treatment 2 completed NCT02824055
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics No drug interventions treatment 1 completed NCT01880255
rTMS for Working Memory Deficits in Schizophrenia No drug interventions treatment Not Available completed NCT00337350
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment No drug interventions prevention 4 completed NCT00047450
Antidepressant Treatment in Older Adults With Schizophrenia treatment Not Available completed NCT02011750
Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia No drug interventions treatment 4 completed NCT03921450
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) No drug interventions treatment Not Available completed NCT01658150
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder No drug interventions supportive_care Not Available completed NCT04298450
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention No drug interventions health_services_research Not Available recruiting NCT05598450
rTMS for Auditory Hallucinations Guided by Magnetoencephalography No drug interventions treatment Not Available recruiting NCT00428350
Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic No drug interventions treatment 4 completed NCT03669250
CVN058 Effect on Mismatch Negativity in Schizophrenics No drug interventions treatment 1 completed NCT01043250
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients No drug interventions Not Available Not Available completed NCT03675750
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism No drug interventions Not Available Not Available unknown_status NCT05276050
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) No drug interventions treatment Not Available recruiting NCT01399450
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients No drug interventions treatment 4 completed NCT00375050
Treatment of Refractory Schizophrenia With Riluzole No drug interventions treatment Not Available completed NCT00216723
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder No drug interventions Not Available Not Available completed NCT02192723
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia No drug interventions treatment Not Available completed NCT04738123
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) No drug interventions treatment 3 completed NCT05919823
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia No drug interventions treatment 3 recruiting NCT00176423
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia treatment 4 completed NCT02755623
Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations No drug interventions treatment Not Available recruiting NCT02409823
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics No drug interventions Not Available Not Available completed NCT00249223
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia No drug interventions treatment 3 completed NCT02149823
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations No drug interventions basic_science 1 terminated NCT00257023
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia treatment 2 completed NCT00838123
Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00320723
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia No drug interventions treatment 4 completed NCT01494623
The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory No drug interventions treatment Not Available completed NCT02305823
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis No drug interventions treatment 4 completed NCT01934023
Effects of Varenicline on Plasticity in Schizophrenia No drug interventions Not Available 2 completed NCT00001323
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia No drug interventions Not Available Not Available completed NCT04123223
Comparing Cognitive Remediation Approaches for Schizophrenia No drug interventions treatment Not Available unknown_status NCT01515423
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia No drug interventions treatment 3 completed NCT00514423
How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs No drug interventions prevention Not Available completed NCT00518323
A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients No drug interventions treatment 3 completed NCT00205608
Microglia Activation in Schizophrenia No drug interventions diagnostic 1 completed NCT02873208
A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia No drug interventions treatment 3 completed NCT05954208
Vısual Arts Group Therapy Based On Watson's Human Care Model In Indıvıduals Wıth Schızophrenıa No drug interventions supportive_care Not Available completed NCT00934908
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine No drug interventions prevention Not Available withdrawn NCT06179108
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia No drug interventions treatment 2 recruiting NCT02878408
Immuno-Genetic, Inflammation, Retro-Virus, Environment No drug interventions basic_science Not Available recruiting NCT00294008
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) No drug interventions Not Available Not Available completed NCT00177008
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety treatment 4 completed NCT00240708
A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00695708
Training-induced Cerebral Reorganization in Schizophrenia No drug interventions Not Available Not Available completed NCT02773108
Somatic Comorbidities in Psychiatric Patients No drug interventions Not Available Not Available completed NCT02834208
Emotion Endophenotypes in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00763438
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia No drug interventions treatment 4 completed NCT00166738
Analysis of Genomic DNA Alterations in Familial Schizophrenia No drug interventions Not Available Not Available unknown_status NCT05968638
Ketogenic Diet in People With Schizophrenia No drug interventions treatment Not Available recruiting NCT01834638
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680) No drug interventions treatment 2 terminated NCT03802838
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia No drug interventions treatment 4 unknown_status NCT02203838
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia No drug interventions treatment 3 completed NCT03896438
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 No drug interventions treatment Not Available active_not_recruiting NCT00784238
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants No drug interventions treatment 4 completed NCT00316238
A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia No drug interventions treatment 2 completed NCT01885338
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia No drug interventions treatment 1 completed NCT03915938
Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain No drug interventions treatment 2 / 3 completed NCT03220438
TMS Enhancement of Visual Plasticity in Schizophrenia No drug interventions basic_science Not Available terminated NCT05491538
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness No drug interventions treatment Not Available recruiting NCT05213143
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine No drug interventions treatment 4 terminated NCT04745143
Monotherapy of an NMDA Enhancer for Schizophrenia No drug interventions treatment 2 recruiting NCT02743143
Long-Term Exercise Training Therapy Versus Usual Care in Patients With Schizophrenia No drug interventions prevention Not Available completed NCT00392743
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT01185743
Antipsychotics and Gene Expression in Soft Tissues No drug interventions basic_science 4 completed NCT00423943
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia No drug interventions treatment 4 completed NCT01674543
Clinical Symptoms of Schizophrenia and Physical Exercise No drug interventions treatment Not Available completed NCT02921243
Schizophrenia and the Gut Microbiome No drug interventions Not Available Not Available completed NCT04327843
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) No drug interventions treatment 3 completed NCT03007303
The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients No drug interventions Not Available Not Available unknown_status NCT05227703
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia No drug interventions treatment 2 active_not_recruiting NCT04267003
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia No drug interventions basic_science Not Available recruiting NCT01066403
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia No drug interventions basic_science Not Available completed NCT00945503
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. No drug interventions treatment 1 completed NCT00316303
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder No drug interventions treatment 2 completed NCT01378403
Evaluation of Dorsal Visual Stream in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00727103
Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia No drug interventions treatment 4 completed NCT01595503
Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available terminated NCT01052103
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms No drug interventions treatment 2 completed NCT03537703
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia No drug interventions basic_science Not Available completed NCT02181803
MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) No drug interventions treatment 1 completed NCT01851603
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects No drug interventions treatment 1 terminated NCT01947803
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia No drug interventions treatment 4 completed NCT00567203
A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia No drug interventions treatment 1 completed NCT00546403
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00669903
Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia No drug interventions treatment 2 terminated NCT04312503
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" No drug interventions Not Available Not Available completed NCT02062190
Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia No drug interventions prevention 2 completed NCT05262790
The Difference of Grey Matter Volume Among the Patients of Schizophrenia No drug interventions Not Available Not Available completed NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial No drug interventions treatment 4 recruiting NCT00628290
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis No drug interventions treatment 2 completed NCT05748990
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia No drug interventions basic_science Not Available recruiting NCT05227690
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia No drug interventions treatment 2 active_not_recruiting NCT01512290
Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations No drug interventions treatment Not Available completed NCT01496690
Pregablin for Anxiety-comorbidity in Patients With Schizophrenia No drug interventions treatment 4 completed NCT03090490
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals No drug interventions treatment Not Available unknown_status NCT05964790
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia No drug interventions treatment 1 / 2 not_yet_recruiting NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder No drug interventions treatment 3 recruiting NCT03093064
Inflammatory Response In Schizophrenia No drug interventions basic_science 1 completed NCT05273164
State Representation in Early Psychosis No drug interventions basic_science Not Available recruiting NCT00672464
Cardio Risk of Acute Schizophrenia Olanzapine Duke No drug interventions prevention 4 withdrawn NCT03316664
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis No drug interventions treatment Not Available completed NCT03775564
Effectiveness of the RemedRugby Program No drug interventions treatment Not Available completed NCT01300364
Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia No drug interventions treatment 4 unknown_status NCT02413164
Multimodal Physical Therapy Program in Schizophrenia No drug interventions treatment Not Available completed NCT00073164
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia treatment 2 completed NCT00469664
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia No drug interventions treatment 4 unknown_status NCT06502964
Study of ALTO-101 in Patients With Schizophrenia No drug interventions treatment 2 recruiting NCT00148564
Energy Homeostasis Under Treatment With Atypical Antipsychotics treatment 4 completed NCT00711464
Modafinil Effects on Cognition in Schizophrenia Patients No drug interventions treatment 4 completed NCT06107764
Cerebellar Modulation of Cognition in Psychosis No drug interventions other Not Available recruiting NCT01101464
A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) No drug interventions basic_science 2 completed NCT00269464
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype? No drug interventions Not Available Not Available completed NCT02188121
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients No drug interventions treatment 4 completed NCT01176721
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia No drug interventions treatment 2 completed NCT00001921
Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings No drug interventions Not Available Not Available completed NCT00759421
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02916121
Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT05208021
The Effect of Psychoeducation Program on Healthy Living Behaviors No drug interventions prevention Not Available unknown_status NCT05978921
Physical Exercise in Patients With Schizophrenia No drug interventions health_services_research Not Available not_yet_recruiting NCT04554121
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing No drug interventions treatment Not Available enrolling_by_invitation NCT02639702
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia No drug interventions treatment 4 recruiting NCT04787302
PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing No drug interventions basic_science 1 completed NCT05716802
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia No drug interventions treatment Not Available completed NCT02431702
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform No drug interventions treatment 3 completed NCT04025502
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects No drug interventions Not Available Not Available completed NCT00645502
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. No drug interventions treatment 1 completed NCT02400502
Integrated Coping and Awareness Training No drug interventions treatment Not Available completed NCT02054702
Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia No drug interventions treatment 3 completed NCT00206102
A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT05321602
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 1 completed NCT06286202
Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial No drug interventions treatment Not Available not_yet_recruiting NCT00225602
Assertive Community Treatment in Copenhagen No drug interventions treatment Not Available unknown_status NCT00111202
Schizophrenia and Genetic Counseling No drug interventions Not Available Not Available unknown_status NCT02968602
Minocycline and Tobacco Craving in Smokers With Schizophrenia No drug interventions other 4 completed NCT00303602
Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) No drug interventions treatment 4 completed NCT01422902
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults No drug interventions treatment 2 completed NCT01975584
Neuroendocrine and Immune Response to Stress in Schizophrenia No drug interventions other Not Available completed NCT00212784
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) treatment 3 completed NCT02634684
Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia. No drug interventions treatment 2 completed NCT02205684
Effects of Physical Activity in Psychosis No drug interventions treatment Not Available unknown_status NCT03838484
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia No drug interventions basic_science Not Available terminated NCT01894984
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia No drug interventions Not Available Not Available terminated NCT00780884
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients No drug interventions treatment Not Available completed NCT01425684
Brain Circuits in Schizophrenia and Smoking No drug interventions Not Available Not Available completed NCT02716584
Benefits of Physical Exercise in Schizophrenia No drug interventions treatment Not Available completed NCT03071484
Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of Psychosis No drug interventions treatment Not Available unknown_status NCT00236379
A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT03345979
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia No drug interventions treatment 3 completed NCT00283179
Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia No drug interventions treatment 3 completed NCT02087579
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants No drug interventions basic_science 1 completed NCT00761579
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission No drug interventions treatment 4 completed NCT00184379
Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness No drug interventions treatment Not Available completed NCT01551979
Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia No drug interventions treatment Not Available completed NCT04411979
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia No drug interventions treatment Not Available completed NCT02105779
Optimizing Cognitive Remediation Outcomes in Schizophrenia No drug interventions treatment Not Available completed NCT03288779
Theta Burst Stimulation for Schizophrenia No drug interventions treatment Not Available completed NCT00742079
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia No drug interventions treatment 4 completed NCT01979679
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone No drug interventions treatment 3 completed NCT02055287
Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 1 completed NCT01801787
Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT06484387
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals With a Diagnosis of Schizophrenia. No drug interventions basic_science Not Available not_yet_recruiting NCT02204787
Treatment of Negative Symptoms and Schizophrenia No drug interventions treatment 1 / 2 completed NCT03971487
Ocrelizumab for Psychosis by Autoimmunity No drug interventions treatment 1 / 2 recruiting NCT03465787
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia No drug interventions treatment 3 completed NCT06182787
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient No drug interventions Not Available Not Available recruiting NCT00000387
Self-Management Therapy for Youth With Schizophrenia No drug interventions treatment 3 completed NCT00750087
Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR No drug interventions Not Available Not Available completed NCT05389787
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study No drug interventions treatment Not Available recruiting NCT00232687
A Switch Study of BMS-337039 in Schizophrenic Out-patients treatment 4 completed NCT01077687
Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan No drug interventions Not Available Not Available completed NCT03092687
Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core No drug interventions Not Available Not Available terminated NCT01617187
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) No drug interventions treatment 3 completed NCT02051387
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study No drug interventions treatment 1 completed NCT00254787
Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients treatment 2 completed NCT01817387
Enhancing Motivation in Recent Onset Schizophrenia No drug interventions treatment Not Available terminated NCT00573287
First Episode Schizophrenia and Cannabis-Related Disorder Study No drug interventions treatment Not Available completed NCT02248987
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia No drug interventions Not Available Not Available completed NCT01377233
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia No drug interventions treatment 2 completed NCT03188133
Visual Information Processing in Schizophrenia Patients With Visual Hallucinations No drug interventions basic_science Not Available unknown_status NCT00376233
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia No drug interventions Not Available Not Available completed NCT02709733
Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia No drug interventions treatment Not Available completed NCT00159133
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia treatment 4 completed NCT02331433
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects No drug interventions treatment 1 completed NCT03544333
Boost rTMS for Auditory Verbal Hallucinations No drug interventions treatment Not Available terminated NCT02072954
Bioequivalence Fasting Study in Patients No drug interventions treatment 2 / 3 completed NCT03900754
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia No drug interventions treatment 2 terminated NCT00815854
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects No drug interventions other Not Available completed NCT04072354
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No drug interventions treatment 3 completed NCT01672554
Clinical Benefits of Seroquel XR in Anxiety Disorder No drug interventions treatment 3 unknown_status NCT06407154
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave No drug interventions Not Available Not Available recruiting NCT00817154
Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) No drug interventions health_services_research 1 completed NCT01606254
A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia No drug interventions treatment 2 completed NCT04314154
Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients No drug interventions Not Available Not Available unknown_status NCT04503954
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia No drug interventions treatment Not Available completed NCT00706654
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01004354
Vitamin D Supplementation in Psychiatric Illnesses No drug interventions treatment Not Available completed NCT06482554
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. No drug interventions treatment 3 recruiting NCT03388554
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01157351
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated No drug interventions prevention 4 completed NCT02504151
Cannabidiol Treatment in Patients With Early Psychosis No drug interventions treatment 2 completed NCT00836251
Effects of Antipsychotic Medications on Energy Intake and Expenditure No drug interventions Not Available Not Available completed NCT03772951
The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia No drug interventions treatment 4 completed NCT00968851
Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia No drug interventions treatment 2 completed NCT01941251
Navigated αTMS in Treatment-resistant Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT06105151
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers No drug interventions treatment 1 recruiting NCT04673851
Horyzons: Implementation in Clinical Practice No drug interventions treatment Not Available completed NCT00143351
Mozart Relapse Study treatment 3 completed NCT00372151
L-Theanine in the Management of Schizophrenia No drug interventions treatment 3 completed NCT06423651
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders No drug interventions treatment Not Available recruiting NCT06236451
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia No drug interventions treatment 4 recruiting NCT02170051
Improving Negative Symptoms of Psychosis In Real-world Environments No drug interventions treatment Not Available completed NCT00324051
Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet No drug interventions treatment 4 completed NCT00936351
Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia No drug interventions treatment Not Available completed NCT03839251
Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients No drug interventions treatment 4 completed NCT05956951
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation No drug interventions basic_science Not Available recruiting NCT03801551
Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia. No drug interventions diagnostic Not Available completed NCT05500651
Dance and Movement Therapy in Patients With Schizophrenia No drug interventions prevention Not Available completed NCT03386851
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder No drug interventions Not Available Not Available completed NCT02175251
Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia No drug interventions treatment Not Available completed NCT01198353
Effectiveness of Ziprasidone for Patients With Schizophrenia No drug interventions treatment 4 completed NCT00288353
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes treatment 3 terminated NCT00995553
Remediation of Working Memory in Schizophrenia No drug interventions treatment Not Available completed NCT05046353
D-serine AudRem: R33 Phase No drug interventions treatment 1 / 2 suspended NCT03543553
From Brain Currents to Interpersonal Flow: Investigating the Social Processing Stream of Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting NCT03050853
The Appeal and Impact of E-cigarettes in Smokers With SMI No drug interventions other Not Available completed NCT02906553
The Role of Nitric Oxide in Cognition in Schizophrenia No drug interventions basic_science Not Available completed NCT01850953
Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia No drug interventions other 4 completed NCT05130853
Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT03062553
Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation No drug interventions treatment Not Available withdrawn NCT00701753
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses No drug interventions Not Available Not Available terminated NCT02034253
Glutamate, Brain Connectivity and Duration of Untreated Psychosis No drug interventions Not Available Not Available completed NCT04779177
Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 1 completed NCT00407277
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia No drug interventions basic_science Not Available completed NCT00369577
Staccato Loxapine in Agitation (Proof of Concept) No drug interventions treatment 2 completed NCT00526877
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment No drug interventions treatment 4 completed NCT01143077
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents No drug interventions treatment 3 completed NCT01161277
Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning No drug interventions basic_science 4 completed NCT00797277
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia No drug interventions treatment 3 completed NCT01663077
Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients No drug interventions treatment 4 completed NCT01292577
Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia No drug interventions treatment 1 / 2 completed NCT00511277
Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study No drug interventions treatment 4 completed NCT03627377
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness No drug interventions prevention Not Available unknown_status NCT00177177
L-carnosine for Schizophrenia treatment Not Available completed NCT00790777
A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville No drug interventions treatment 1 completed NCT05945277
Critical Time Intervention-Peer Support No drug interventions treatment Not Available recruiting NCT02976077
RC2S+: Remediation of Social Cognitive Impairments No drug interventions treatment Not Available completed NCT01250847
Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) No drug interventions treatment 4 unknown_status NCT02670447
Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies No drug interventions Not Available Not Available not_yet_recruiting NCT02146547
European Long-acting Antipsychotics in Schizophrenia Trial No drug interventions treatment 4 completed NCT01009047
An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia No drug interventions treatment 3 completed NCT00743847
A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia No drug interventions treatment 2 withdrawn NCT00833547
Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia No drug interventions Not Available Not Available completed NCT05211947
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study No drug interventions treatment 3 recruiting NCT03077347
The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia No drug interventions basic_science Not Available terminated NCT05339347
Schizophrenia Treatment With Photoneuromodulation No drug interventions treatment 2 unknown_status NCT05326347
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia No drug interventions treatment 3 recruiting NCT00297947
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder No drug interventions treatment 2 / 3 completed NCT03183947
Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms No drug interventions treatment Not Available completed NCT01980147
Skills for Wellness No drug interventions prevention Not Available recruiting NCT00071747
Clinical Study Of Schizophrenia in Both Men and Women treatment 3 completed NCT00001247
Inpatient Evaluation of Adults With Schizophrenia No drug interventions Not Available Not Available recruiting NCT00383747
The Effects of Nicotine on Cognition in Schizophrenia No drug interventions treatment 4 completed NCT02085447
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness No drug interventions supportive_care Not Available completed NCT00832845
Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study No drug interventions treatment Not Available completed NCT02538445
Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia No drug interventions Not Available Not Available completed NCT03842345
DELPhI Evaluation of Psychiatric Conditions No drug interventions Not Available Not Available withdrawn NCT00658645
Efficacy of Bifeprunox in Patients With Schizophrenia No drug interventions treatment 3 terminated NCT02697045
Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch No drug interventions treatment 4 completed NCT00825045
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT03790345
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics No drug interventions treatment 2 / 3 unknown_status NCT00523445
The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00312598
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine No drug interventions Not Available Not Available completed NCT04173598
Cognitive Remediation Program for Family Caregivers in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT00541398
Antipsychotic Polypharmacy: Prevalence, Background and Consequences No drug interventions health_services_research Not Available completed NCT02935998
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation No drug interventions treatment 4 unknown_status NCT00225498
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade treatment Not Available completed NCT00485498
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics No drug interventions treatment 4 completed NCT01561898
A Long-Term Study of JNS007ER in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00056498
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine treatment 4 completed NCT01092598
Factors Association With Poor Physical Function in Older Adults With Schizophrenia No drug interventions Not Available Not Available completed NCT00686998
Phase IIA Study in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00558298
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. No drug interventions treatment 3 completed NCT03965598
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group No drug interventions Not Available Not Available unknown_status NCT00420498
Effects of Atomoxetine on Cognitive Function in Schizophrenia No drug interventions treatment 2 completed NCT03714698
Effects of Pilates Exercise Program in Patients With Schizophrenia No drug interventions health_services_research Not Available completed NCT00616798
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia. No drug interventions treatment 2 completed NCT05343598
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia No drug interventions basic_science Not Available recruiting NCT00677898
A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) No drug interventions health_services_research Not Available completed NCT00486005
Weight Gain Management in Patients With Schizophrenia No drug interventions treatment 4 completed NCT05025605
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder No drug interventions treatment 1 recruiting NCT02386605
Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers No drug interventions treatment Not Available completed NCT05823805
Approaches For ThE pRioritization of Patients in priMAry Care Post-COVID To Reduce Health Inequities (AFTERMATH) No drug interventions prevention Not Available not_yet_recruiting NCT04010305
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia No drug interventions treatment 1 completed NCT00350805
Measuring Time Windows in Patients With Schizophrenia and Healthy Controls No drug interventions Not Available Not Available completed NCT02932605
Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia No drug interventions basic_science Not Available completed NCT03131505
INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 No drug interventions Not Available Not Available completed NCT03040505
Future Mental Projections in Schizophrenia No drug interventions Not Available Not Available terminated NCT00044005
Safety and Tolerability Study of Drug to Treat Schizophrenia treatment 2 completed NCT02930005
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders No drug interventions treatment 2 completed NCT03287505
Aripiprazole IM Depot for Chinese Patients With Schizophrenia No drug interventions other 1 completed NCT00999505
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia No drug interventions treatment 3 unknown_status NCT04506905
Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011) No drug interventions treatment 1 completed NCT01357005
Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan No drug interventions Not Available Not Available unknown_status NCT04025905
Social Cognition Training and Vocational Rehabilitation No drug interventions other Not Available recruiting NCT01905605
Phosphatidylcholine Supplementation in Infants No drug interventions prevention 1 / 2 withdrawn NCT00308997
Transcranial Magnetic Stimulation for "Voices" No drug interventions treatment 2 completed NCT01794897
Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia No drug interventions basic_science 4 completed NCT04610697
Cognitive Remediation in Forensic Mental Health Care No drug interventions treatment Not Available recruiting NCT05805397
Effectiveness of Motivation Skills Training (MST) No drug interventions treatment Not Available recruiting NCT02539797
Improving Cognition in Schizophrenia Using tDCS No drug interventions treatment Not Available completed NCT00272597
Risperidone LA Heathcare Resource Study treatment 4 completed NCT01555697
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia No drug interventions health_services_research 1 / 2 completed NCT03379597
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder No drug interventions treatment Not Available completed NCT00320697
Smoking Relapse Prevention in Schizophrenia No drug interventions treatment 4 completed NCT00172497
Aggressive Acts Among Patients With Schizophrenia No drug interventions Not Available Not Available suspended NCT00256997
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication No drug interventions treatment 4 terminated NCT01324297
The Topical Niacin Skin Flush Test in First Episode Psychosis No drug interventions Not Available Not Available terminated NCT01456897
A Long-term Trial of OPC-34712 in Patients With Schizophrenia No drug interventions treatment 3 completed NCT03929497
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms No drug interventions treatment 2 terminated NCT05670197
Service User and Staff Views on Digital Remote Monitoring for Psychosis No drug interventions Not Available Not Available recruiting NCT06123897
Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study No drug interventions Not Available Not Available recruiting NCT04118283
Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness No drug interventions treatment Not Available recruiting NCT04857983
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia No drug interventions treatment 2 / 3 recruiting NCT01215383
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy No drug interventions Not Available Not Available unknown_status NCT00378183
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. No drug interventions treatment 4 completed NCT02748083
Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic No drug interventions treatment Not Available completed NCT03037983
Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation No drug interventions supportive_care Not Available completed NCT00523783
Seroquel Long-Term NIS for Schizophrenia Patients No drug interventions Not Available Not Available completed NCT02040883
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia No drug interventions treatment 4 unknown_status NCT02246283
Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia No drug interventions Not Available Not Available completed NCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode No drug interventions treatment Not Available recruiting NCT02426983
Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination No drug interventions Not Available 1 / 2 unknown_status NCT00350883
Cognitive Therapy for Negative Symptoms and Functioning No drug interventions treatment 2 completed NCT01795183
Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia No drug interventions treatment 4 completed NCT00465283
Donepezil Double Blind Trial for ECT Memory Disfunction No drug interventions treatment 4 unknown_status NCT00705783
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00124683
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 treatment 2 completed NCT05316883
Biomarkers in Clozapine-responding Schizophrenia No drug interventions basic_science 4 recruiting NCT06456983
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial No drug interventions treatment Not Available not_yet_recruiting NCT01481883
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? No drug interventions treatment 4 completed NCT00639483
Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia No drug interventions treatment 2 completed NCT05835583
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia No drug interventions supportive_care Not Available completed NCT00391261
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. No drug interventions treatment 4 completed NCT00036361
Broad Effectiveness: Study With Aripiprazole treatment 3 completed NCT01682161
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate No drug interventions treatment 4 completed NCT01942161
A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia No drug interventions treatment 2 / 3 completed NCT00289861
Risperidone Augmentation in Patients With Schizophrenia treatment 4 completed NCT03190161
Music to Reduce Use of Smoking in Patients With Schizophrenia No drug interventions supportive_care Not Available completed NCT04761861
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia No drug interventions treatment 2 recruiting NCT01244828
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) No drug interventions treatment 3 completed NCT02334228
Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness No drug interventions prevention Not Available completed NCT01060228
A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men No drug interventions Not Available 1 completed NCT02006628
A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder No drug interventions treatment 2 completed NCT00206128
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia treatment 3 completed NCT02715128
Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex No drug interventions basic_science Not Available unknown_status NCT01606228
A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia No drug interventions treatment 3 completed NCT05741528
An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication No drug interventions treatment 3 enrolling_by_invitation NCT01594528
Behavior During Experimentally Induced Pain No drug interventions prevention Not Available completed NCT00230828
Patient-reported Outcomes in the Treatment of Schizophrenia treatment 3 completed NCT01435928
PEARL Schizophrenia Maintenance No drug interventions treatment 3 completed NCT03007628
Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia No drug interventions treatment Not Available completed NCT00216528
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres treatment 4 completed NCT00458211
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics No drug interventions treatment 4 completed NCT02640911
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT01291511
Relapse Prevention Study in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02665611
Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence No drug interventions treatment Not Available unknown_status NCT00650611
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders No drug interventions treatment 2 completed NCT01295411
Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03576911
A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective Disorder No drug interventions treatment Not Available unknown_status NCT01981811
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder No drug interventions treatment 2 withdrawn NCT01714011
Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome No drug interventions treatment 4 completed NCT05948111
Assessment of Schizophrenia Patients' Clinical Study Experiences No drug interventions Not Available Not Available not_yet_recruiting NCT03409393
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis No drug interventions supportive_care Not Available completed NCT00702793
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA) No drug interventions treatment 4 withdrawn NCT01222793
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia No drug interventions Not Available Not Available completed NCT02453893
Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia No drug interventions treatment 3 unknown_status NCT04922593
Relative Bioavailability of LY03010 Compared to Listed Drug No drug interventions treatment 1 completed NCT01914393
Pediatric Open-Label Extension Study No drug interventions treatment 3 completed NCT00086593
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia treatment 3 completed NCT00888693
A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia No drug interventions treatment 1 completed NCT01760993
Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia No drug interventions treatment 3 terminated NCT01992393
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) No drug interventions supportive_care Not Available completed NCT06574893
Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index No drug interventions treatment Not Available recruiting NCT02137993
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia No drug interventions treatment 4 completed NCT00320671
Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis No drug interventions treatment 4 completed NCT00418171
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) No drug interventions treatment 4 completed NCT00436371
Amisulpride in Schizophrenic Acute Phase Patients No drug interventions treatment 4 completed NCT00103571
Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia treatment 4 completed NCT04134871
Walking for Health: an Intervention to Increase Physical Activity and Reduce Sedentary Behaviour in People With SMI No drug interventions treatment Not Available completed NCT03150771
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia No drug interventions supportive_care 1 completed NCT00366171
Open Label Extension Study of Bifeprunox No drug interventions treatment 3 completed NCT00249171
A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients treatment 4 completed NCT00515671
Illness Management and Recovery for Veterans With Severe Mental Illness No drug interventions treatment Not Available completed NCT00186771
Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia No drug interventions treatment 4 unknown_status NCT00539071
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone No drug interventions treatment 4 completed NCT04024371
Validating Reward-related Biomarkers (RTOC) No drug interventions Not Available Not Available completed NCT01242371
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT00796471
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations No drug interventions treatment 1 completed NCT03172871
Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia No drug interventions treatment 3 completed NCT00178971
Serotonin 1A Agonists and Cognition in Schizophrenia treatment 3 completed NCT03059771
Mobile Enhancement of Motivation in Schizophrenia No drug interventions treatment Not Available completed NCT02110771
Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia No drug interventions treatment Not Available completed NCT00004571
Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT01186471
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients No drug interventions Not Available 0 completed NCT01394471
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia No drug interventions treatment 1 completed NCT02451371
Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia No drug interventions treatment 1 / 2 completed NCT02390271
How Reducing Anxiety in Schizophrenia No drug interventions prevention 4 completed NCT04033978
Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia No drug interventions treatment Not Available terminated NCT00328978
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects No drug interventions treatment 3 completed NCT05193578
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes No drug interventions treatment 2 completed NCT00757978
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms No drug interventions treatment 4 completed NCT01362478
Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00423878
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder No drug interventions treatment 4 completed NCT02242578
Treating Refractory Schizophrenia With rTMS No drug interventions treatment Not Available terminated NCT03130478
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain No drug interventions Not Available Not Available completed NCT03209778
Involuntary Memories Investigation in Schizophrenia No drug interventions health_services_research Not Available terminated NCT06043778
Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India No drug interventions treatment Not Available not_yet_recruiting NCT00088478
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia treatment 3 completed NCT02091388
Bioavailability of LY03004 and Risperdal® Consta® No drug interventions treatment 1 completed NCT04020588
Anti-inflammatories and Adolescent Schizophrenia treatment 4 unknown_status NCT03807388
ReMindCare App for Patients From First Episode of Psychosis Unit. No drug interventions treatment Not Available unknown_status NCT00036088
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia treatment 4 completed NCT00249288
Folate Supplementation in Schizophrenia treatment 4 completed NCT02805088
Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability? No drug interventions Not Available Not Available unknown_status NCT02200588
Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP No drug interventions Not Available Not Available unknown_status NCT05100888
Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms No drug interventions treatment Not Available enrolling_by_invitation NCT02201888
Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study No drug interventions treatment Not Available completed NCT00297388
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 3 completed NCT03114488
Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation No drug interventions basic_science Not Available completed NCT01427088
rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia No drug interventions basic_science Not Available completed NCT00155207
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03143907
Mindfulness Group-based Intervention for Early Psychosis No drug interventions treatment Not Available completed NCT00645307
A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia. No drug interventions treatment 3 completed NCT00905307
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia No drug interventions treatment 2 completed NCT00694707
Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia No drug interventions treatment 2 completed NCT02868307
Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers No drug interventions supportive_care Not Available unknown_status NCT00992407
An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 4 completed NCT04681807
Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia No drug interventions treatment Not Available recruiting NCT05168007
Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia No drug interventions treatment 3 unknown_status NCT00816907
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) No drug interventions treatment 4 completed NCT05204407
Luteolin for the Treatment of People With Schizophrenia No drug interventions treatment Not Available recruiting NCT00057707
Effects of Modafinil on Brain Function in Patients With Schizophrenia other 1 completed NCT00222807
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus No drug interventions Not Available Not Available completed NCT01879709
Yoga as Cognitive Remediation in Schizophrenia No drug interventions Not Available Not Available completed NCT01409109
Database Registry for Neural Network Biomarkers in Psychosis No drug interventions Not Available Not Available active_not_recruiting NCT00184509
Continued Early Intervention for Recent-onset Schizophrenia No drug interventions treatment 3 terminated NCT00239109
Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. treatment 4 completed NCT00704509
Efficacy of Bifeprunox in Patients With Schizophrenia No drug interventions treatment 3 terminated NCT03183609
Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) No drug interventions treatment Not Available recruiting NCT00506909
Oxytocin Add on Study for Stable Schizophrenic Patients No drug interventions treatment Not Available terminated NCT00717509
Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT01055509
Compensatory Strategies Applied to Cognitive Impairment in Schizophrenia No drug interventions treatment Not Available completed NCT02219009
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole No drug interventions treatment 2 completed NCT06502509
Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study No drug interventions supportive_care Not Available completed NCT02501109
Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers No drug interventions treatment 1 completed NCT02302209
Dyad Oxytocin Study (DOS) No drug interventions other 1 completed NCT01315509
Dental Status of Patients With Severe Mental Illness No drug interventions Not Available Not Available completed NCT01701609
Cognitive Remediation Therapy (CRT) in Adolescents With EOS No drug interventions treatment Not Available completed NCT00358709
Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions No drug interventions treatment 3 completed NCT02142556
The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics No drug interventions treatment 3 completed NCT00833456
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT01167556
Family Motivational Intervention in Schizophrenia No drug interventions treatment Not Available unknown_status NCT00594256
Sodium Oxybate in Schizophrenia With Insomnia No drug interventions treatment 2 completed NCT00893256
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia No drug interventions treatment 4 completed NCT02566356
Adult Study Oxytocin - fMRI No drug interventions treatment 0 completed NCT01626456
A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) No drug interventions treatment 3 completed NCT01792856
Coaching Intervention for Patients With Early Psychosis No drug interventions treatment Not Available unknown_status NCT00646256
Cognitive Determinants of Psychoeducation and Information in Psychoses No drug interventions treatment Not Available unknown_status NCT05278156
Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia No drug interventions treatment 2 completed NCT03034356
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia No drug interventions other 1 / 2 completed NCT00774085
An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone No drug interventions Not Available Not Available completed NCT01026285
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics No drug interventions Not Available Not Available completed NCT00229385
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) diagnostic Not Available completed NCT01615185
A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia No drug interventions treatment 4 terminated NCT00246285
A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia No drug interventions treatment 3 completed NCT00946985
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years No drug interventions prevention 4 terminated NCT02848885
The Effects of tDCS on Illness Awareness in Schizophrenia No drug interventions basic_science Not Available recruiting NCT05469815
Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients No drug interventions other Not Available not_yet_recruiting NCT00425815
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia No drug interventions treatment 2 withdrawn NCT03666715
A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal No drug interventions Not Available Not Available completed NCT00645515
A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia No drug interventions treatment 3 terminated NCT02901015
Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning No drug interventions diagnostic Not Available completed NCT00150215
A First In Human Study Of PF-00184562 In Healthy Volunteers treatment 1 completed NCT00156715
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder other 4 completed NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone No drug interventions treatment 4 completed NCT04414215
Cognitive Training for Emotion Regulation in Psychotic Disorders No drug interventions treatment Not Available recruiting NCT00382915
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder No drug interventions Not Available Not Available completed NCT00255515
Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia treatment 4 completed NCT02420015
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia No drug interventions treatment 4 completed NCT01636037
Antipsychotic Augmentation With L-Dopa No drug interventions treatment 2 completed NCT04325737
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia No drug interventions treatment 1 completed NCT00156637
A Study of Strategies to Improve Schizophrenia Treatment No drug interventions Not Available Not Available completed NCT00770237
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia No drug interventions diagnostic Not Available completed NCT00456937
Escitalopram in Schizophrenia in OCD- Open Label Study No drug interventions Not Available 4 completed NCT03552237
Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients No drug interventions supportive_care Not Available unknown_status NCT00247637
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia No drug interventions Not Available Not Available completed NCT01399437
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia No drug interventions Not Available Not Available completed NCT01300637
Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients No drug interventions treatment Not Available unknown_status NCT02421237
Trial of Treatment for Internalized Stigma in Schizophrenia No drug interventions treatment Not Available completed NCT04481737
Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery No drug interventions treatment Not Available completed NCT05127837
CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies No drug interventions treatment Not Available enrolling_by_invitation NCT01621737
Antipsychotic Effects of Oxytocin No drug interventions treatment Not Available terminated NCT03608137
Cannabis and Thought Disorder in Schizophrenia No drug interventions basic_science Not Available terminated NCT02907437
Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia No drug interventions treatment 3 unknown_status NCT03245437
Target Engagement and Response to Oxytocin No drug interventions treatment 4 active_not_recruiting NCT05662137
The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients No drug interventions supportive_care Not Available completed NCT00791232
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia No drug interventions treatment 1 completed NCT02013232
Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia No drug interventions treatment Not Available unknown_status NCT06278532
Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS No drug interventions Not Available Not Available recruiting NCT02188732
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes No drug interventions supportive_care Not Available completed NCT02304432
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine No drug interventions treatment 0 completed NCT00666432
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes No drug interventions Not Available Not Available completed NCT00581932
Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine No drug interventions Not Available Not Available completed NCT06231732
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study No drug interventions treatment Not Available recruiting NCT01259232
The Imaging Genetic Study of Schizophrenia and Family No drug interventions Not Available Not Available unknown_status NCT03246932
Peer-led Psycho-education for Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT00848432
Risperidone Maintenance Treatment in Schizophrenia No drug interventions prevention 4 completed NCT01754532
Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels No drug interventions Not Available Not Available completed NCT02949232
Prednisolone Addition for Patients With Recent-onset Psychotic Disorder No drug interventions treatment 4 terminated NCT00178932
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors No drug interventions diagnostic Not Available recruiting NCT02320032
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia No drug interventions treatment 1 completed NCT00302432
The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study No drug interventions Not Available Not Available completed NCT02730832
Validation of a Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00796432
A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone No drug interventions treatment 1 completed NCT00338832
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia No drug interventions treatment 3 completed NCT01246232
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia No drug interventions treatment 4 completed NCT00535132
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone No drug interventions treatment 4 completed NCT03697252
A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia No drug interventions treatment 2 completed NCT00358852
Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00877552
Prospective Studies of the Pathogenesis of Schizophrenia No drug interventions Not Available Not Available completed NCT01895452
An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) No drug interventions treatment 3 completed NCT04629352
Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination No drug interventions basic_science Not Available recruiting NCT02234752
Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia No drug interventions treatment 2 terminated NCT00169052
Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People No drug interventions treatment Not Available completed NCT06563752
Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers No drug interventions treatment Not Available not_yet_recruiting NCT00629252
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients No drug interventions basic_science Not Available terminated NCT03117452
Evaluation of a Visual Remediation Intervention for Schizophrenia No drug interventions treatment Not Available unknown_status NCT06061952
CAE for Poorly Adherent Individuals With Schizophrenia No drug interventions other Not Available recruiting NCT00235352
Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia treatment 2 / 3 completed NCT01355952
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia No drug interventions treatment Not Available completed NCT05023252
Mobile Self-Tracking No drug interventions health_services_research Not Available recruiting NCT01625000
Safety and Efficacy of MP-214 in Patients With Schizophrenia No drug interventions treatment 2 / 3 completed NCT04325100
Intervention Targeting Motivational Negative Symptoms No drug interventions treatment Not Available completed NCT01969500
Development of a Mobile System for Self-management of Schizophrenia (SOS) No drug interventions treatment Not Available completed NCT01617200
Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) No drug interventions treatment 3 completed NCT06115200
Norwegian Adult Mental Health Registry No drug interventions Not Available Not Available not_yet_recruiting NCT03432000
Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia No drug interventions other Not Available unknown_status NCT04590300
Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs No drug interventions supportive_care Not Available completed NCT01781000
Cerebral Reorganization in Schizophrenia No drug interventions treatment Not Available completed NCT03701100
The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia No drug interventions treatment Not Available completed NCT03975400
Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis No drug interventions screening Not Available completed NCT00370500
Quetiapine and the Dopaminergic Epigenetic Control No drug interventions diagnostic 4 completed NCT00821600
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia No drug interventions treatment 1 completed NCT00291200
Enhancing the Prospective Prediction of Psychosis No drug interventions Not Available Not Available completed NCT01641900
Effects of Eszopiclone on Sleep and Memory in Schizophrenia No drug interventions treatment Not Available completed NCT00644800
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis No drug interventions treatment 4 completed NCT01307800
A Study of LY2140023 in Patients With Schizophrenia No drug interventions treatment 3 terminated NCT03575000
Bromocriptine for Patients With Schizophrenia and Prediabetes No drug interventions treatment 4 not_yet_recruiting NCT00573300
Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study No drug interventions Not Available Not Available completed NCT00351000
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus No drug interventions treatment 4 completed NCT03075800
Integration of Illness Management and Recovery Within ACT No drug interventions treatment Not Available completed NCT02974400
Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis No drug interventions treatment Not Available completed NCT02926859
Enhancing Recovery in Early Schizophrenia No drug interventions treatment 2 recruiting NCT01235559
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) No drug interventions treatment 3 completed NCT01101659
Ketamine Challenge Study With JNJ-40411813 No drug interventions basic_science 1 completed NCT01959659
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness No drug interventions Not Available Not Available completed NCT00153959
Psychiatric Day Hospital Treatment No drug interventions Not Available Not Available completed NCT00042159
Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations No drug interventions treatment Not Available completed NCT03643159
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder No drug interventions health_services_research 4 terminated NCT01164059
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia No drug interventions treatment 4 completed NCT01284959
Different Safety Profile of Risperidone and Paliperidone Extended-release No drug interventions Not Available 4 completed NCT00528359
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS No drug interventions Not Available Not Available completed NCT01569659
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia No drug interventions treatment 4 completed NCT02547259
Influence of Emotion in a Test Run Forgetfulness No drug interventions diagnostic Not Available completed NCT02942459
Music Therapy Towards Schizophrenia, Negative Symptoms No drug interventions treatment Not Available unknown_status NCT01724359
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia No drug interventions treatment 4 completed NCT00688259
Cognitive-Behavioral Therapy in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT00246259
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis No drug interventions treatment 4 completed NCT02577575
Adult Oxytocin Study No drug interventions treatment 0 completed NCT00088075
Investigate Risperidone for the Treatment of Schizophrenia in Adolescents treatment 3 completed NCT00725075
Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) No drug interventions treatment 2 completed NCT00947375
Lamictal TM, Haloperidol Decanoate in Schizophrenia No drug interventions treatment 4 terminated NCT01212575
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia No drug interventions Not Available Not Available completed NCT05770375
Tolerability of MDMA in Schizophrenia No drug interventions treatment 1 / 2 not_yet_recruiting NCT04144075
Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial. No drug interventions treatment Not Available unknown_status NCT00250575
A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia treatment 3 completed NCT04072575
A Study of Paliperidone Palmitate 6-Month Formulation No drug interventions treatment 3 completed NCT01037075
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence No drug interventions Not Available Not Available completed NCT00565175
Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia No drug interventions treatment 4 completed NCT01716975
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy No drug interventions treatment 3 completed NCT01420575
Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia No drug interventions treatment Not Available terminated NCT03140475
Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition No drug interventions Not Available Not Available recruiting NCT00034775
A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. treatment 3 completed NCT00749970
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients treatment 3 completed NCT00172770
The Establishment of the Early Intervention Program for Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT04714970
rTMS on Appetite and Cognitive Function in Schizophrenia No drug interventions prevention Not Available active_not_recruiting NCT04309370
Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia No drug interventions treatment Not Available completed NCT03656770
Measuring Beliefs and Norms About Persons With Mental Illness No drug interventions other Not Available completed NCT02451670
Reducing Cardiovascular Risk in Adults With Serious Mental Illness No drug interventions treatment Not Available completed NCT00512070
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine No drug interventions treatment Not Available active_not_recruiting NCT00206570
Clinical Estradiol Trial in Women With Schizophrenia treatment 2 completed NCT00339170
Cognitive Training and Enhanced Supported Employment in Schizophrenia No drug interventions treatment Not Available completed NCT05654870
Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia No drug interventions treatment 3 terminated NCT00548470
Varenicline Effects In Schizophrenic Smokers No drug interventions treatment 4 completed NCT00712270
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia No drug interventions treatment 4 terminated NCT05660070
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness No drug interventions treatment Not Available active_not_recruiting NCT00220870
Shared Decision Making for Schizophrenia No drug interventions prevention Not Available completed NCT01558570
Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin No drug interventions Not Available Not Available completed NCT00435370
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia No drug interventions treatment 3 completed NCT03345342
A Study of Paliperidone Palmitate 6-Month Formulation No drug interventions treatment 3 completed NCT05105542
M1 Schizophrenia PET Study No drug interventions diagnostic 2 completed NCT01561742
Minocycline Augmentation in Schizophrenia No drug interventions treatment Not Available unknown_status NCT01175642
Cognitive Remediation and Functional Skills Training in Schizophrenia No drug interventions treatment 0 completed NCT01812642
A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia No drug interventions treatment 2 completed NCT00894842
Study of a Neurocognition Enhancing Agent in Patients With Schizophrenia No drug interventions treatment 2 / 3 completed NCT01206842
Social Cognition Training in Schizophrenia No drug interventions treatment Not Available completed NCT02532842
Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate No drug interventions Not Available Not Available completed NCT00996242
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00097942
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients treatment 2 completed NCT03128099
Virtual Reality Training for Social Skills in Schizophrenia No drug interventions basic_science Not Available completed NCT04520399
Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning No drug interventions Not Available Not Available unknown_status NCT00518999
Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points No drug interventions Not Available Not Available unknown_status NCT02205099
A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia No drug interventions treatment 1 / 2 completed NCT02978599
Clinical Trial of AVL-3288 in Schizophrenia Patients No drug interventions treatment 1 completed NCT04220099
Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia No drug interventions Not Available Not Available completed NCT01139099
The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00245206
Side Effects of Newer Antipsychotics in Older Adults treatment 4 completed NCT00202306
Indicated Prevention of Psychotic Disorders With Low-dose Lithium treatment 4 completed NCT00723606
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation No drug interventions treatment 3 completed NCT01091506
A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients No drug interventions supportive_care Not Available completed NCT02286206
Study of the Effect of Dosing on Clozapine Levels No drug interventions other 4 withdrawn NCT03163706
Evaluation of Stroop Effect in Patients With Schizophrenia No drug interventions other Not Available unknown_status NCT00779506
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) No drug interventions treatment 4 completed NCT00653406
A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients No drug interventions treatment 1 / 2 completed NCT00654706
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02572206
PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations No drug interventions basic_science 1 terminated NCT01189006
Add-On Therapy to Risperidonein Schizophrenia No drug interventions treatment 2 / 3 completed NCT00357006
A Definitive Estrogen Patch Study (ADEPT) No drug interventions treatment 2 completed NCT01363349
Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia No drug interventions treatment 2 / 3 terminated NCT00190749
Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT00514449
Systematic Evaluation of Antiviral Medication in Schizophrenia No drug interventions treatment 2 completed NCT00492349
Varenicline Adjunctive Treatment in Schizophrenia No drug interventions treatment 4 completed NCT02391649
Problem-solving-based Bibliotherapy Program for Family Caregivers No drug interventions health_services_research Not Available completed NCT02819349
Texting for Relapse Prevention No drug interventions prevention Not Available completed NCT00791349
A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone No drug interventions treatment 1 completed NCT06572449
Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia No drug interventions treatment 3 not_yet_recruiting NCT03708549
Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients No drug interventions treatment 4 unknown_status NCT05299749
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations No drug interventions treatment Not Available recruiting NCT02431949
The Music Study in Refractory Psychosis No drug interventions Not Available Not Available unknown_status NCT02715349
Psychoeducation for Vietnamese Families With a Patient With Schizophrenia No drug interventions treatment Not Available completed NCT00034749
The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia treatment 3 completed NCT01788436
A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers No drug interventions Not Available 0 completed NCT03061136
Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia No drug interventions treatment 4 withdrawn NCT00813436
The Effect of Intranasal Administration of Oxytocin on Empathic Abilities. No drug interventions treatment 2 unknown_status NCT00492336
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia No drug interventions treatment 4 completed NCT00176436
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients No drug interventions treatment 4 completed NCT02769936
Glutamate, Learning, and Working Memory No drug interventions basic_science 1 completed NCT02582736
Antipsychotics and Risk of Hyperglycemic Emergencies No drug interventions Not Available Not Available completed NCT00351936
A Placebo-Controlled, Cross-Over Trial of Aripiprazole No drug interventions treatment 4 completed NCT05159336
Transcranial Alternating Current Stimulation (tACS) for Auditory Hallucinations No drug interventions treatment Not Available unknown_status NCT00817336
Biomarkers in Schizophrenia No drug interventions treatment 2 completed NCT06136936
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia No drug interventions treatment Not Available completed NCT04182113
rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia No drug interventions treatment Not Available completed NCT05145413
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT01479413
Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs No drug interventions Not Available Not Available completed NCT03593213
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia No drug interventions treatment 3 terminated NCT02360813
Cognitive Remediation Therapy Within a Secure Forensic Setting No drug interventions treatment Not Available completed NCT01878513
Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis No drug interventions treatment Not Available completed NCT01714713
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy No drug interventions treatment 3 completed NCT01992913
Building Employment Skills Through Therapy for Veterans No drug interventions treatment Not Available completed NCT00280813
Alcohol Use Disorders in Schizophrenia No drug interventions treatment Not Available completed NCT00522613
Recovery Group Pilot No drug interventions supportive_care Not Available completed NCT00696813
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics No drug interventions Not Available Not Available completed NCT00193713
Bifeprunox in the Treatment of Schizophrenia treatment 3 completed NCT02576613
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT06482918
Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms No drug interventions treatment Not Available recruiting NCT00155818
Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia No drug interventions Not Available Not Available completed NCT00591318
A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis No drug interventions treatment 1 / 2 terminated NCT00882518
Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients No drug interventions treatment 3 completed NCT02166918
Factors Influencing Social Functioning of People With Schizophrenia No drug interventions Not Available Not Available completed NCT05563818
Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00714818
Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness No drug interventions Not Available 3 completed NCT01138618
Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ) No drug interventions Not Available Not Available completed NCT00547118
The Effects of Rimonabant, on Weight and Metabolic Risk Factors No drug interventions treatment 2 terminated NCT00255918
Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients No drug interventions treatment 1 completed NCT00857818
Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome No drug interventions treatment 3 terminated NCT00951418
Serum Clozapine and Cognition No drug interventions Not Available Not Available completed NCT02884518
Predicting Antipsychotic Discontinuation in Psychosis No drug interventions treatment Not Available unknown_status NCT00406718
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia No drug interventions treatment Not Available completed NCT00184418
The Immune System and Psychiatric Disorders No drug interventions Not Available Not Available completed NCT01081418
Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders No drug interventions treatment 4 completed NCT00161018
New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia treatment 3 completed NCT01819818
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients No drug interventions Not Available Not Available completed NCT00249119
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia No drug interventions treatment 3 completed NCT02128919
Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic No drug interventions treatment Not Available completed NCT02261519
Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults No drug interventions treatment 2 / 3 terminated NCT02418819
A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia No drug interventions basic_science 1 completed NCT02329119
Psychiatric Disorders and Electrophysiological Markers No drug interventions Not Available Not Available unknown_status NCT00139919
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder treatment 2 completed NCT02074319
RCT of Methotrexate Added to Treatment As Usual in Schizophrenia No drug interventions treatment 1 completed NCT03882619
Effectiveness of Using Calligraphic Activity to People With Schizophrenia No drug interventions treatment Not Available completed NCT04518319
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome No drug interventions treatment 2 suspended NCT00584519
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight No drug interventions Not Available Not Available completed NCT03101319
Role of Vitamin D Supplementation in Schizophrenia No drug interventions treatment Not Available completed NCT00802919
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors No drug interventions treatment 4 completed NCT03404219
Motivation and Skills Support (MASS) No drug interventions health_services_research Not Available completed NCT04461119
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia No drug interventions treatment 2 completed NCT04177719
Neurobiological Effects of Oxytocin in Schizophrenia No drug interventions other Not Available unknown_status NCT02911519
Brief Group Psychoeducation for Schizophrenia No drug interventions treatment Not Available completed NCT01952041
A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia No drug interventions treatment Not Available completed NCT01495741
Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) No drug interventions Not Available Not Available completed NCT05556941
Metacognitive Intervention for Individuals With Severe Mental Disorders No drug interventions treatment Not Available completed NCT02212041
Electronic Cigarettes in Smokers With Mental Illness No drug interventions other Not Available completed NCT00892541
A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone No drug interventions treatment 1 completed NCT02657941
Early and Short Psycho-educational Lifestyle Intervention No drug interventions prevention Not Available terminated NCT00254241
Safety and Efficacy of Seroquel in First Episode Schizophrenia treatment 4 completed NCT04602741
Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement No drug interventions treatment Not Available completed NCT00964041
Once Weekly D-cycloserine for Schizophrenia No drug interventions treatment 4 withdrawn NCT02600741
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) No drug interventions Not Available Not Available completed NCT03510741
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. No drug interventions other 2 completed NCT00129441
Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study treatment 2 completed NCT01110317
A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate No drug interventions treatment 1 completed NCT00215917
D-Serine Monotherapy for Schizophrenia treatment 1 / 2 unknown_status NCT00563017
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone No drug interventions treatment Not Available unknown_status NCT02724917
Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia No drug interventions treatment 1 / 2 suspended NCT00356317
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia No drug interventions treatment 2 completed NCT01206517
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) No drug interventions treatment 1 completed NCT00573417
A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia No drug interventions treatment 4 completed NCT02796417
The Efficacy of REHACOP Program in Schizophrenia No drug interventions treatment Not Available completed NCT00210717
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia No drug interventions treatment 3 completed NCT02433717
A Pharmacokinetic Study of Paliperidone ER No drug interventions treatment 4 unknown_status NCT00156117
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) treatment 3 completed NCT02453217
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial No drug interventions health_services_research Not Available completed NCT00377117
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II No drug interventions Not Available Not Available completed NCT00149734
Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia treatment 3 completed NCT00399334
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders No drug interventions Not Available Not Available completed NCT05206734
Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health No drug interventions Not Available Not Available completed NCT02842034
Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients. No drug interventions treatment Not Available unknown_status NCT06376734
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness No drug interventions basic_science 2 not_yet_recruiting NCT01150734
Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation) No drug interventions Not Available Not Available completed NCT03848234
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder No drug interventions treatment 3 completed NCT01181934
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects. No drug interventions Not Available 0 completed NCT02593734
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana No drug interventions treatment 4 completed NCT04580134
CLOZAPINE Response in Biotype-1 No drug interventions treatment 4 recruiting NCT00088634
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia treatment 2 completed NCT00567034
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects No drug interventions supportive_care 1 completed NCT01749124
My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness No drug interventions health_services_research Not Available unknown_status NCT03829124
Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy No drug interventions treatment 4 unknown_status NCT05443724
A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia No drug interventions treatment 2 recruiting NCT00090324
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia treatment 3 completed NCT00688324
Biomarker Study of Acamprosate in Schizophrenia No drug interventions treatment 4 completed NCT00095524
Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT00963924
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available completed NCT02565524
the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder. No drug interventions diagnostic Not Available completed NCT00151424
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) treatment 3 completed NCT01045824
Family-based Genetic Long-term Study of Brain Function in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00380224
Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia. No drug interventions treatment 3 completed NCT00601224
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia No drug interventions treatment 1 completed NCT04533724
Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia No drug interventions treatment 0 unknown_status NCT02474524
Self-Management and Recovery Technology Psychosocial Intervention Trial No drug interventions treatment Not Available completed NCT05338424
Exercise Target Brain Oscillations in Psychosis No drug interventions Not Available Not Available withdrawn NCT01876524
tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients No drug interventions treatment Not Available completed NCT00304616
SWitching to Abilify Trial (SWAT) No drug interventions treatment 4 completed NCT01780116
Effectiveness of Adherence Therapy for Schizophrenia No drug interventions health_services_research 1 / 2 completed NCT06036316
Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis No drug interventions diagnostic Not Available recruiting NCT06174116
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia No drug interventions treatment 4 recruiting NCT05877716
EPI-MINN: Targeting Cognition and Motivation - National No drug interventions treatment Not Available recruiting NCT06470516
The Hi-tACS on Cognitive Function in Patients With Schizophrenia No drug interventions treatment Not Available recruiting NCT04946916
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease No drug interventions diagnostic Not Available recruiting NCT03251716
Berberine Treat Metabolic Syndrome in Schizophrenia No drug interventions treatment Not Available completed NCT05165316
European Long-acting Antipsychotics in Schizophrenia Trial-II No drug interventions Not Available Not Available enrolling_by_invitation NCT00419016
Association Between Schizophrenia and Cancer No drug interventions Not Available Not Available completed NCT02627716
Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder No drug interventions prevention Not Available unknown_status NCT02708316
The Gut Metagenome Research of Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00931996
Oculomotor and Spatial Cognition Deficits in Schizophrenia No drug interventions basic_science Not Available terminated NCT00145496
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) treatment 3 completed NCT00708396
Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study No drug interventions treatment 4 unknown_status NCT02423096
Neuroendocrine and Metabolite Substrates in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT06303596
Hippotherapy in Patients With Schizophrenia No drug interventions supportive_care Not Available not_yet_recruiting NCT02307396
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients No drug interventions treatment 4 completed NCT03179696
Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT03637296
Adapting Critical Time Intervention to Support Inpatient Medical Care Transition No drug interventions treatment Not Available terminated NCT00894296
Magnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on Treatments No drug interventions Not Available Not Available unknown_status NCT04393896
Assessing a WeChat-based Integrative Family Intervention (WIFI) for Schizophrenia No drug interventions health_services_research Not Available unknown_status NCT00861796
Study of CYR-101 in Patients With Schizophrenia No drug interventions treatment 2 completed NCT02594696
Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness No drug interventions health_services_research Not Available completed NCT01035996
Dopamine Function and Reward Processing In Schizophrenia No drug interventions Not Available Not Available completed NCT03872596
Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder No drug interventions basic_science 1 completed NCT00895258
Cognitive Training to Improve Work Outcomes in Severe Mental Illness No drug interventions treatment 2 completed NCT02335658
Long-term Study of DSP-5423P in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01043458
Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia No drug interventions treatment 1 completed NCT01339858
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia No drug interventions treatment 4 completed NCT00178958
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia No drug interventions prevention Not Available completed NCT00828958
Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients. No drug interventions treatment 3 completed NCT02983058
PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations No drug interventions basic_science Not Available terminated NCT06002958
Horyzons: Implementation and Integration in Clinical Practice No drug interventions treatment Not Available recruiting NCT02678858
Efficacy of ISST in Schizophrenia No drug interventions treatment Not Available completed NCT03868358
Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients No drug interventions treatment Not Available completed NCT02093858
The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome No drug interventions Not Available Not Available unknown_status NCT01809158
Minocycline for Schizophrenia No drug interventions treatment 4 completed NCT04127058
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia No drug interventions treatment 1 completed NCT03713658
A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities No drug interventions health_services_research 4 completed NCT00001258
Studies of Frontal Lobe Brain Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT00554658
Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients No drug interventions Not Available 4 completed NCT02603458
NRX-1074 in Early Course Schizophrenia No drug interventions treatment 2 withdrawn NCT04002258
Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment No drug interventions Not Available Not Available completed NCT00796835
A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone No drug interventions treatment 1 completed NCT01071135
Quetiapine XR in Schizophrenic Patients No drug interventions treatment 3 terminated NCT05693935
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia No drug interventions treatment 3 active_not_recruiting NCT00334035
Antipsychotic Therapy and First Episode No drug interventions Not Available 4 completed NCT01063335
Imaging Cannabinoid CB1 Receptors in Schizophrenia No drug interventions Not Available Not Available terminated NCT01214135
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia No drug interventions Not Available Not Available completed NCT00734435
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects No drug interventions treatment 2 terminated NCT00350935
Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study No drug interventions Not Available Not Available completed NCT03972735
Assessment of the Effectiveness of the NECT Program No drug interventions treatment Not Available unknown_status NCT00269035
SPECT Study With SB-773812 In Schizophrenic Patients No drug interventions treatment 1 completed NCT02787135
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis No drug interventions treatment Not Available completed NCT00222235
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia treatment 2 / 3 completed NCT01959035
Aripiprazole Once-monthly in Patients With Schizophrenia No drug interventions treatment 3 completed NCT00934635
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls No drug interventions treatment 4 terminated NCT05140135
Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy No drug interventions treatment Not Available withdrawn NCT04940663
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness No drug interventions basic_science Not Available recruiting NCT05783063
iTBS for Increased Appetite Induced by Antipsychotics No drug interventions treatment Not Available recruiting NCT02720263
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia No drug interventions treatment 1 completed NCT00488163
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia No drug interventions treatment 4 completed NCT05961163
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study No drug interventions Not Available Not Available terminated NCT05329363
Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients No drug interventions supportive_care Not Available recruiting NCT02453763
In Vivo Imaging of Therapeutic Electric Current Flow No drug interventions Not Available Not Available completed NCT03376763
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics No drug interventions treatment 4 completed NCT00300963
Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients No drug interventions treatment 2 completed NCT00501163
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients No drug interventions Not Available Not Available completed NCT01325363
Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic Patients No drug interventions basic_science Not Available completed NCT01556763
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia No drug interventions treatment 1 completed NCT02529163
Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms No drug interventions treatment Not Available unknown_status NCT01346163
Add On Treatment for Cognitive Deficits in Schizophrenia No drug interventions treatment 1 completed NCT00330863
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy No drug interventions treatment 4 completed NCT06474286
Prucalopride for Cognitive Functioning in Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT02086786
Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia No drug interventions treatment 2 completed NCT00206986
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia? treatment Not Available completed NCT01196286
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis No drug interventions treatment Not Available completed NCT03891186
Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol No drug interventions supportive_care Not Available completed NCT01578486
Salsalate as an Adjunctive Treatment for Patients With Schizophrenia No drug interventions treatment 4 completed NCT01620086
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia No drug interventions treatment Not Available completed NCT01831986
Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders No drug interventions treatment Not Available unknown_status NCT01577186
Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER) No drug interventions treatment 4 completed NCT01209039
A Repeat Dose Positron Emission Tomography Study With GSK1144814 No drug interventions treatment 1 completed NCT05245539
Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia No drug interventions treatment 1 completed NCT00078039
Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia treatment 3 completed NCT03273439
A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia No drug interventions treatment Not Available completed NCT04368039
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis No drug interventions treatment Not Available recruiting NCT02953639
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics No drug interventions treatment 2 completed NCT01940939
Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in Schizophrenia No drug interventions treatment Not Available completed NCT01469039
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia No drug interventions treatment 3 completed NCT05252039
Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis No drug interventions treatment Not Available recruiting NCT00663039
Effects of Oxytocin Nasal Spray on Social Affiliation No drug interventions other 2 completed NCT00237939
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices treatment 3 completed NCT02823639
Efficacy and Mechanisms of Transcranial Direct Current Stimulation (tDCS) - Effects on Working Memory in Schizophrenia No drug interventions basic_science Not Available unknown_status NCT01457339
Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia No drug interventions other 1 completed NCT03356639
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT05686239
A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) No drug interventions treatment 2 recruiting NCT00825539
Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia No drug interventions treatment 1 / 2 completed NCT03868839
Telmisartan Pilot Study on Treatment Resistant Schizophrenia No drug interventions other 2 terminated NCT03071939
Cognate Patient Care Insight Scale No drug interventions other Not Available withdrawn NCT04940039
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings No drug interventions treatment 4 completed NCT06159322
Characterizing Response to Antipsychotics in Schizophrenia No drug interventions Not Available Not Available recruiting NCT05870722
An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research No drug interventions Not Available Not Available not_yet_recruiting NCT03630822
Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder No drug interventions supportive_care Not Available completed NCT05901922
The Effect of Social Skills Intervention on Praxis and Social Functioning in Individuals With Schizophrenia No drug interventions treatment Not Available completed NCT00791622
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine No drug interventions treatment 1 completed NCT00954122
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia No drug interventions treatment 4 completed NCT06515522
A Biological Signature for the Early Differential Diagnosis of Psychosis No drug interventions Not Available Not Available not_yet_recruiting NCT06142422
Intermittent Theta Burst Stimulation of the Precuneus No drug interventions treatment Not Available not_yet_recruiting NCT00534222
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect No drug interventions Not Available Not Available completed NCT02505022
Role Functioning Changes NOS No drug interventions Not Available Not Available terminated NCT04548622
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results No drug interventions treatment Not Available terminated NCT00223522
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data? No drug interventions Not Available Not Available completed NCT00631722
Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia No drug interventions treatment Not Available completed NCT00892125
A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder No drug interventions treatment 1 completed NCT06063525
Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic Boundary No drug interventions Not Available Not Available active_not_recruiting NCT00864825
Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia No drug interventions treatment 4 completed NCT03930225
Effectiveness of A Stigma Directed Interventional Program in Schizophrenia No drug interventions health_services_research Not Available suspended NCT00689325
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics No drug interventions Not Available Not Available completed NCT03671525
Cognitive Effects of Nimodipine in Patients With Schizophrenia No drug interventions other 0 completed NCT00183625
Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients treatment 4 completed NCT00990925
Lifestyle Modification for Weight Loss in Schizophrenia No drug interventions treatment Not Available completed NCT01923025
A PET Study With RO5545965 in Healthy Male Volunteers No drug interventions Not Available 1 completed NCT03809325
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly No drug interventions Not Available Not Available completed NCT00331825
Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism No drug interventions treatment 4 completed NCT02069925
STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S. No drug interventions treatment Not Available completed NCT03863925
Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy No drug interventions treatment 4 completed NCT01116830
A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder No drug interventions treatment 1 completed NCT04703530
Effect of Hot Footbath on the Sleep Quality No drug interventions treatment Not Available completed NCT00482430
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) No drug interventions treatment 2 completed NCT02260830
Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 No drug interventions treatment 1 completed NCT04807530
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging No drug interventions treatment Not Available recruiting NCT03273530
Integrated Supported Employment in Mainland China No drug interventions treatment Not Available completed NCT04184830
Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation No drug interventions treatment Not Available completed NCT04860830
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia No drug interventions treatment 3 active_not_recruiting NCT00261430
A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone. No drug interventions treatment 4 completed NCT00817648
A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia No drug interventions treatment 4 completed NCT01167348
The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT05259748
The Effect of Psychoeducation on Healthy Lifestyle Behaviors in Individuals With Schizophrenia No drug interventions supportive_care Not Available completed NCT01662648
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia No drug interventions treatment 3 completed NCT00237848
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia treatment 3 completed NCT00497848
The Compliance Project Concerning People With Schizophrenia No drug interventions Not Available Not Available completed NCT01829048
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia No drug interventions basic_science 1 completed NCT05661448
Promoting Cognitive Health in Schizophrenia No drug interventions treatment Not Available recruiting NCT04078048
Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia No drug interventions treatment Not Available completed NCT04871048
Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia No drug interventions treatment Not Available recruiting NCT06236048
Energetics and Glutamate in Schizophrenia No drug interventions Not Available Not Available recruiting NCT00080548
Timing of Voluntary Movement in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00236548
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection treatment 3 completed NCT00634348
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients No drug interventions treatment 4 completed NCT04395157
Optimizing Cognitive Remediation No drug interventions Not Available Not Available recruiting NCT02658357
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant No drug interventions treatment 2 completed NCT05233657
A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule No drug interventions treatment 1 unknown_status NCT00159757
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients No drug interventions treatment 4 terminated NCT04497857
Academic-Community EPINET (AC-EPINET) No drug interventions health_services_research Not Available recruiting NCT01519557
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders No drug interventions treatment 0 completed NCT03261557
Cognitive Behavioral Social Skills Training in Early Onset Psychosis No drug interventions treatment Not Available unknown_status NCT05110157
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia No drug interventions treatment 3 recruiting NCT01804257
Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study No drug interventions health_services_research Not Available completed NCT00206557
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study treatment 2 completed NCT03304457
Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia No drug interventions treatment 4 completed NCT00236457
A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT01858857
Geriatric Psychiatry and Pharmacovigilance No drug interventions Not Available Not Available unknown_status NCT01649557
Multicenter, Open-label, Safety and Tolerability Study No drug interventions treatment 2 completed NCT00952757
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine No drug interventions Not Available Not Available completed NCT04839926
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects No drug interventions basic_science 1 unknown_status NCT00562926
Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese No drug interventions Not Available Not Available completed NCT01623726
Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia No drug interventions treatment 2 withdrawn NCT00105326
Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients treatment 2 completed NCT01362426
Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL) No drug interventions Not Available Not Available completed NCT00845026
A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients No drug interventions treatment 2 completed NCT03238326
Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia No drug interventions supportive_care 3 active_not_recruiting NCT02411526
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia No drug interventions treatment 1 completed NCT02246426
Treatment of Social Cognition in Schizophrenia Trial No drug interventions treatment Not Available completed NCT00481026
A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression No drug interventions treatment Not Available completed NCT03911726
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia No drug interventions basic_science Not Available recruiting NCT01795326
Physician Survey on Monitoring of Patients Treated With Quetiapine No drug interventions Not Available Not Available completed NCT03271866
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome No drug interventions treatment Not Available recruiting NCT06389266
Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia No drug interventions basic_science Not Available recruiting NCT00158366
Reducing the Weight of Overweight Schizophrenia Patients No drug interventions treatment Not Available completed NCT01909466
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia No drug interventions treatment 1 completed NCT01373866
Multimodal MRI-guided rTMS to Treat Refractory Hallucinations No drug interventions treatment Not Available completed NCT00411866
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 No drug interventions diagnostic 1 completed NCT01622166
Art Therapy in Acute Schizophrenia No drug interventions treatment Not Available completed NCT02360566
Participatory Video as a Recovery-Oriented Intervention in Early Psychosis No drug interventions treatment Not Available completed NCT01193166
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital No drug interventions prevention 4 withdrawn NCT02824666
Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 No drug interventions treatment 1 completed NCT00934466
Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) No drug interventions diagnostic 1 completed NCT01584466
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study No drug interventions treatment Not Available withdrawn NCT00361166
Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone No drug interventions treatment 2 completed NCT01832766
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes No drug interventions Not Available 1 / 2 terminated NCT01104766
Safety and Efficacy of Cariprazine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01550666
Treatment Development Targeting Severe and Persistent Negative Symptoms No drug interventions supportive_care Not Available completed NCT06005766
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care No drug interventions treatment Not Available recruiting NCT00179465
Treating Schizophrenia by Correcting Abnormal Brain Development treatment 3 active_not_recruiting NCT02715765
The Use of Transcranial Electrical Stimulation for Hallucinations No drug interventions treatment Not Available terminated NCT00100165
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia treatment 2 completed NCT00690365
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia No drug interventions Not Available Not Available completed NCT01506765
Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia No drug interventions treatment 1 completed NCT05068765
The Effect of the Psychoeducation Program on the Subjective Well-being of Caregivers No drug interventions health_services_research Not Available unknown_status NCT02421965
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness No drug interventions treatment Not Available completed NCT06184165
Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation No drug interventions treatment Not Available not_yet_recruiting NCT00396565
A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia No drug interventions treatment 3 completed NCT01706965
Kuvan in People With Schizophrenia and Schizoaffective Disorder No drug interventions treatment 1 / 2 completed NCT03481465
Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis No drug interventions Not Available Not Available unknown_status NCT00174265
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) treatment 3 completed NCT05939765
Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study. No drug interventions Not Available Not Available recruiting NCT03994965
The Sub-Sero Study No drug interventions treatment 2 withdrawn NCT00156065
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) treatment 3 completed NCT00007774
To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia Not Available 4 completed NCT01041274
DECIFER: Depression and Citalopram In First Episode Recovery No drug interventions treatment 4 completed NCT01266174
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults No drug interventions treatment 2 completed NCT01465074
Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia No drug interventions basic_science Not Available terminated NCT00431574
Antipsychotic Medication Extended Dosing Study No drug interventions treatment Not Available completed NCT01129674
A Long-Term, Open-Label, Study on Schizophrenia No drug interventions treatment 2 / 3 terminated NCT00690274
Study to Demonstrate Cognitive Enhancing Effects of BF2.649 No drug interventions treatment 2 completed NCT02037074
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics No drug interventions treatment 1 completed NCT02150174
Testing Effect and Schizophrenia No drug interventions supportive_care Not Available completed NCT06301074
The Phase I Study of HS-10509 in Chinese Adult Subjects No drug interventions treatment 1 not_yet_recruiting NCT01173874
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone No drug interventions treatment 3 completed NCT04011774
Planning Your Everyday Life in Virtual Reality : a Study in Schizophrenia; No drug interventions other Not Available unknown_status NCT02736474
Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia No drug interventions treatment 4 completed NCT00892320
A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers No drug interventions treatment 1 completed NCT01010620
Screening Protocol for Research Participants No drug interventions Not Available Not Available completed NCT00001320
Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients No drug interventions Not Available Not Available completed NCT00086320
A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia. treatment 3 completed NCT02634320
A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia No drug interventions treatment 4 completed NCT05157620
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness No drug interventions treatment Not Available recruiting NCT02477020
A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia No drug interventions treatment 2 completed NCT05296720
EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia No drug interventions basic_science Not Available recruiting NCT00001920
Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia No drug interventions Not Available Not Available completed NCT03055520
Arithmetic Training With the Kumon Method for Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT01598220
Computer Assisted Cognitive Remediation Program in Schizophrenia No drug interventions treatment Not Available completed NCT05257720
Evaluation of the Role of Neurodegeneration in Schizophrenia No drug interventions Not Available Not Available completed NCT01936220
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial No drug interventions treatment Not Available unknown_status NCT00287820
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism treatment 4 completed NCT00159120
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia No drug interventions treatment 4 completed NCT00073320
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia treatment 3 completed NCT00982982
Effects of Delta-9-THC and Iomazenil in Healthy Humans No drug interventions basic_science 0 completed NCT04531982
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia No drug interventions treatment 3 active_not_recruiting NCT01514682
Anti-Inflammatory Treatment of Schizophrenia No drug interventions treatment Not Available completed NCT01036282
Cognitive Skills Training Using Computer for Patients With Severe Mental Illness No drug interventions treatment 4 completed NCT00707382
Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment No drug interventions diagnostic Not Available completed NCT06155682
TMS for Inhibition Enhancement in Schizophrenia No drug interventions other Not Available not_yet_recruiting NCT01050582
A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children No drug interventions treatment 4 completed NCT03404882
Peer Support Experience for Patients Discharged From Acute Psychiatric Care No drug interventions treatment Not Available completed NCT01392482
IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder No drug interventions Not Available Not Available completed NCT00345982
Augmenting Clozapine With Sertindole - SERCLOZ No drug interventions treatment Not Available completed NCT01447082
General Practice Research Database Seroquel XR Safety Study No drug interventions Not Available Not Available completed NCT00986531
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics No drug interventions basic_science 1 completed NCT00179231
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia treatment Not Available completed NCT00588731
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia No drug interventions treatment 2 completed NCT01051531
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia No drug interventions treatment 3 completed NCT00852631
Seroquel XR in Adults With Schizophrenia No drug interventions treatment 3 terminated NCT04252131
Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia No drug interventions treatment 1 completed NCT00824031
Study of Mental Care in Spain No drug interventions Not Available Not Available completed NCT00218231
Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia treatment 2 completed NCT00395031
Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder No drug interventions treatment 2 / 3 completed NCT00566631
An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia No drug interventions treatment 3 completed NCT03557931
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication No drug interventions treatment 2 completed NCT04144231
Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS) No drug interventions treatment Not Available recruiting NCT00172731
Measurement of Activity Participation for Persons With Schizophrenia Living in the Community No drug interventions Not Available Not Available completed NCT05322031
The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia No drug interventions treatment 4 unknown_status NCT03192631
Financial Incentives to Improve Acceptance of Antipsychotic Injections No drug interventions other Not Available unknown_status NCT02831231
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium No drug interventions treatment 1 completed NCT01624831
Social Cognition in Longstanding Psychosis No drug interventions Not Available Not Available terminated NCT00657631
Acceptance and Commitment Therapy for Delusions No drug interventions treatment Not Available completed NCT00304473
Fast Titration in the Treatment of Schizophrenia, Taiwan No drug interventions treatment 3 completed NCT05599373
Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia No drug interventions treatment Not Available recruiting NCT01075373
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations No drug interventions Not Available Not Available unknown_status NCT03338673
Brain Stimulation and Cognitive Training No drug interventions other Not Available completed NCT02462473
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry No drug interventions treatment 2 terminated NCT02975973
Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia No drug interventions treatment Not Available completed NCT02008773
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia No drug interventions treatment 2 completed NCT00984373
Epidemiology of Schizophrenia in Bulgaria No drug interventions Not Available Not Available completed NCT00672373
Extract of Ginkgo Biloba and Tardive Dyskinesia No drug interventions treatment 3 completed NCT04136873
A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT00404573
Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia No drug interventions treatment 2 completed NCT00401973
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine No drug interventions prevention 3 completed NCT00585273
Antipsychotics and Blood Vessel Function No drug interventions Not Available Not Available completed NCT02281773
A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. No drug interventions treatment 2 completed NCT00349973
Clinical Trial of Dipyridamole in Schizophrenia No drug interventions treatment Not Available completed NCT01646827
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia No drug interventions basic_science 1 completed NCT04972227
Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia No drug interventions treatment 1 completed NCT00077727
A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia. treatment 3 completed NCT03408327
The Application of Wearable Technology to Improve the Physical Activity Level of People With Chronic Mental Illness No drug interventions other Not Available completed NCT05974527
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department No drug interventions treatment 4 not_yet_recruiting NCT00209027
The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia Not Available Not Available terminated NCT01191827
fMRI Cholinergic Mechanisms in Schizophrenia No drug interventions Not Available Not Available completed NCT00752427
24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia No drug interventions treatment 3 completed NCT05457127
Obstructive Sleep Apnea Treatment in Serious Mental Illness No drug interventions treatment Not Available not_yet_recruiting NCT04551027
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness No drug interventions treatment Not Available unknown_status NCT04106427
Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS) No drug interventions treatment Not Available completed NCT02734927
Motivation and Executive Control in Schizophrenia No drug interventions basic_science Not Available completed NCT01281527
Paliperidone Palmitate Flexible Dosing in Schizophrenia No drug interventions treatment 3 completed NCT01259427
Reducing Internalized Stigma in People With Serious Mental Illness No drug interventions treatment 2 completed NCT03413527
rTMS Treatment for Positive and Negative Symptoms of Schizophrenia No drug interventions treatment 2 / 3 unknown_status NCT00548327
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype No drug interventions treatment 2 terminated NCT04278027
Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics No drug interventions treatment Not Available unknown_status NCT01888627
Integrated Care in Psychotic Disorders With Severe Mental Illness No drug interventions treatment Not Available recruiting NCT00144027
Patient-Centered Medication Adherence Intervention for Schizophrenia No drug interventions Not Available Not Available completed NCT00036127
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders treatment 2 / 3 completed NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia No drug interventions treatment 4 completed NCT02773576
Safety and Tolerability of Risperidone Implants No drug interventions treatment 3 completed NCT01963676
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT00722176
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 No drug interventions treatment 2 completed NCT00150176
To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) treatment 3 completed NCT05182476
Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia treatment 2 active_not_recruiting NCT00456976
Efficacy of Selegiline in Negative Symptoms of Schizophrenia No drug interventions treatment 0 completed NCT04064476
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk Not Available Not Available unknown_status NCT05240976
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia No drug interventions treatment 2 recruiting NCT06208176
HD-tDCS for Hallucinations No drug interventions treatment Not Available not_yet_recruiting NCT01724476
A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia No drug interventions treatment 4 completed NCT03794076
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia No drug interventions treatment 1 / 2 recruiting NCT01390376
DAAOI-1 Treatment for Treatment-resistant Schizophrenia No drug interventions treatment 2 completed NCT04191876
Financial Incentives to Improve Medication Adherence No drug interventions health_services_research Not Available completed NCT01010776
A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone No drug interventions treatment 4 completed NCT03064776
Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia No drug interventions treatment Not Available completed NCT00308360
Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility treatment 4 completed NCT03919760
Early Psychosis Intervention - Spreading Evidence-based Treatment No drug interventions Not Available Not Available unknown_status NCT05301660
Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia No drug interventions treatment 0 unknown_status NCT00206960
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia diagnostic Not Available completed NCT05243160
Medication Reviews in Severe Mental Illness No drug interventions health_services_research Not Available completed NCT03129360
Levetiracetam in Early Psychosis No drug interventions other 2 completed NCT06574360
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia No drug interventions treatment 2 not_yet_recruiting NCT02088060
A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients No drug interventions treatment 2 active_not_recruiting NCT04086160
Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset No drug interventions treatment Not Available recruiting NCT01869660
Shared Decision Making for Patients With First-admission Schizophrenia No drug interventions treatment 2 / 3 completed NCT05838560
Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders No drug interventions prevention 2 recruiting NCT04065360
Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families No drug interventions treatment Not Available withdrawn NCT05438160
Exploratory Study of the Digital Therapeutics CT-155 in the Treatment of People With Schizophrenia No drug interventions treatment Not Available completed NCT02874560
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia No drug interventions Not Available Not Available completed NCT01181960
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations No drug interventions Not Available Not Available completed NCT01517360
Pharmacological Approach to Improve the Outcome of Social Cognition Training No drug interventions treatment 1 completed NCT03080194
The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia No drug interventions treatment 4 unknown_status NCT02887794
Basic Auditory Processing and Auditory Hallucinations No drug interventions basic_science Not Available completed NCT00781794
Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients No drug interventions other 1 withdrawn NCT02714894
Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study No drug interventions Not Available Not Available unknown_status NCT01375894
Body Movement Imitation and Perspective Perception Among Psychiatric Patients No drug interventions diagnostic Not Available unknown_status NCT03874494
Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia No drug interventions treatment 3 completed NCT00458094
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses No drug interventions treatment Not Available completed NCT01192594
Milestones of Adjustment Post-Psychosis No drug interventions supportive_care 3 terminated NCT03284294
Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia No drug interventions treatment 3 unknown_status NCT00816894
D-serine Monotherapy for Schizophrenia No drug interventions treatment 2 completed NCT00248794
Cognitive Rehabilitation in Schizophrenia No drug interventions treatment Not Available completed NCT01160991
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism No drug interventions basic_science Not Available completed NCT00156091
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) treatment 3 completed NCT00169091
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia treatment 4 terminated NCT01077791
A Study of a Remediation Program of Social Cognition in Schizophrenia No drug interventions treatment 2 terminated NCT03390491
OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis No drug interventions other Not Available completed NCT03729791
The Effect of tDCS on Schizophrenia With Negative Symptoms No drug interventions treatment Not Available unknown_status NCT00085891
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia treatment 3 completed NCT03736291
The Effect of Repetitive Transcranial Magnetic Stimulation in Schizophrenia No drug interventions treatment Not Available withdrawn NCT00071591
Rehabilitative Training for Older People With Schizophrenia No drug interventions Not Available 2 completed NCT02879591
Enhancing Social Interaction With an AlterEgo Artificial Agent No drug interventions Not Available Not Available unknown_status NCT01216891
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis No drug interventions treatment Not Available completed NCT00313391
Risperdal Consta and Health Care Utilization in Patients With Schizophrenia No drug interventions Not Available 4 completed NCT00488891
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia No drug interventions Not Available Not Available terminated NCT05778591
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia No drug interventions treatment 2 not_yet_recruiting NCT04369391
A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia. No drug interventions treatment 1 completed NCT05893862
A Study To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia (MK-8189-019) No drug interventions treatment 1 completed NCT00337662
Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia No drug interventions treatment 4 completed NCT00640562
Quetiapine Extended Release Depression Symptoms No drug interventions treatment 3 completed NCT05200962
Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study No drug interventions basic_science 1 active_not_recruiting NCT03464162
OnTrackNY With the Option of Social Network Meetings No drug interventions treatment Not Available withdrawn NCT00472862
Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual No drug interventions treatment 3 completed NCT00167362
Cognitive Enhancement Therapy for Early-Stage Schizophrenia No drug interventions treatment 3 completed NCT02109562
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients No drug interventions treatment 3 completed NCT00228462
Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo treatment 3 completed NCT02086162
Randomized Controlled Trial (RCT) of a Motivational Decision Support System No drug interventions treatment Not Available completed NCT03899662
Neurophysiological Evaluation of Schizophrenia Patients After Cognitive and Physical Intervention No drug interventions health_services_research Not Available completed NCT02589262
Safety, Blood Levels and Effects of AUT00206 No drug interventions treatment 1 completed NCT01566162
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia No drug interventions treatment 3 completed NCT03608462
Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT03820362
The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique No drug interventions Not Available Not Available completed NCT02880462
A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia No drug interventions treatment 2 completed NCT01524380
Ginkgo Biloba Extract for Schizophrenia No drug interventions treatment Not Available completed NCT00618280
Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail No drug interventions basic_science 1 / 2 completed NCT01660880
Validation of Receptor Occupancy Simulation No drug interventions Not Available Not Available completed NCT03870880
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension No drug interventions treatment 3 completed NCT01133080
Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study No drug interventions treatment 4 unknown_status NCT03829280
Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) No drug interventions treatment Not Available completed NCT02032680
Comparison of E-health vs. In-person Multi-Family Group (MFG) No drug interventions treatment Not Available completed NCT03379480
Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia No drug interventions treatment Not Available completed NCT00224380
Medication Adherence in Older Adults With Serious Mental Illness No drug interventions Not Available Not Available completed NCT00434980
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia No drug interventions treatment Not Available completed NCT06539780
Imagery Rescripting as a Treatment for Early Psychosis No drug interventions treatment Not Available recruiting NCT03240380
Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. No drug interventions treatment Not Available unknown_status NCT00793780
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia No drug interventions treatment Not Available completed NCT04641780
"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program" No drug interventions Not Available Not Available unknown_status NCT03751280
Study of Efficacy of PEAR-004 in Schizophrenia No drug interventions treatment 2 completed NCT01045629
Competence Ability Study in People With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02826629
"Manual Dexterity and Oculomotor Control in Schizophrenia" No drug interventions basic_science Not Available unknown_status NCT00018629
Cognitive - Behavioral Therapy No drug interventions Not Available 2 completed NCT00538629
Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox No drug interventions Not Available Not Available completed NCT04588129
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers No drug interventions basic_science 1 completed NCT02664129
Video as a Tool to Improve Insight in Schizophrenia No drug interventions treatment Not Available completed NCT04987229
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects No drug interventions treatment 3 enrolling_by_invitation NCT05102929
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia No drug interventions basic_science Not Available recruiting NCT02970929
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia No drug interventions treatment 2 completed NCT01053429
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule No drug interventions Not Available Not Available completed NCT01459029
High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia No drug interventions treatment 2 unknown_status NCT05911529
Motivational Interviewing for Patients With Acute Psychosis No drug interventions treatment Not Available completed NCT03281629
Circuitry-Guided Smoking Cessation in Schizophrenia No drug interventions other Not Available completed NCT01602029
Randomized Double Blind Placebo Control Study in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00515489
Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients No drug interventions Not Available Not Available terminated NCT06340789
Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate No drug interventions treatment 2 not_yet_recruiting NCT02661789
Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression No drug interventions basic_science Not Available completed NCT00169689
Repetitive Transcranial Magnetic Stimulation No drug interventions treatment Not Available completed NCT01929889
Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia No drug interventions treatment 4 terminated NCT00694889
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia No drug interventions prevention 1 / 2 completed NCT00401089
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia No drug interventions treatment 1 / 2 completed NCT01299389
An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia No drug interventions treatment 3 completed NCT05039489
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT01052389
Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia No drug interventions treatment 4 completed NCT00892489
A Bioequivalence Study of 15 mg ER OROS Paliperidone No drug interventions treatment 1 completed NCT02744989
STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT00034892
CAFE Comparison of Atypicals in First Episode of Psychosis treatment 3 completed NCT02970292
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1) No drug interventions treatment 3 completed NCT00149292
Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo treatment 2 completed NCT00862992
Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia No drug interventions treatment 2 completed NCT03257592
Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States No drug interventions diagnostic 1 terminated NCT02187692
The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia No drug interventions treatment Not Available completed NCT01047592
Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia No drug interventions treatment 2 completed NCT00378092
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode No drug interventions treatment 4 completed NCT01431092
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia No drug interventions treatment 4 completed NCT04324944
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness No drug interventions treatment Not Available recruiting NCT05090644
Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic Group No drug interventions Not Available Not Available completed NCT04124744
A Pilot Randomised Controlled Trial of a Health Champion Intervention No drug interventions health_services_research Not Available unknown_status NCT01432444
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole No drug interventions treatment 3 completed NCT00145444
Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study treatment 3 completed NCT02176044
The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study No drug interventions basic_science 1 completed NCT00374244
Efficacy of Pimozide Augmentation for Clozapine Partial Response No drug interventions treatment 2 completed NCT05808244
Tele-group Cognitive Behavioural Family Intervention (tgCBFI) for People With Schizophrenia and Their Families No drug interventions treatment Not Available not_yet_recruiting NCT02339844
Pan European Collaboration on Antipsychotic Naïve Schizophrenia II No drug interventions treatment 4 completed NCT02364544
Improving Care and Reducing Cost Study No drug interventions treatment Not Available completed NCT01854944
PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia No drug interventions treatment 1 completed NCT03621540
Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia No drug interventions basic_science Not Available completed NCT03837340
Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health No drug interventions health_services_research Not Available unknown_status NCT01926340
Early Medication Discontinuation and Long-term Clinical Outcome in FEP No drug interventions Not Available Not Available completed NCT01607840
Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia No drug interventions treatment Not Available completed NCT05953740
A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) No drug interventions treatment 1 completed NCT00253240
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population No drug interventions Not Available Not Available completed NCT00288340
Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging No drug interventions treatment Not Available completed NCT00051740
Treating Thought Problems in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT05281640
Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial No drug interventions treatment Not Available completed NCT01654640
The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine No drug interventions treatment 4 terminated NCT00554840
Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia No drug interventions treatment 2 completed NCT05406440
A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014) treatment 1 completed NCT05462340
PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia No drug interventions diagnostic 1 recruiting NCT00094640
Pharmacokinetic Characterization of Intramuscular Olanzapine Depot treatment 1 completed NCT05073640
Pentoxifylline Add-on Therapy for Schizophrenia No drug interventions treatment 1 / 2 unknown_status NCT03318640
Mindfulness and Cognition in Schizophrenia No drug interventions basic_science Not Available terminated NCT04099940
Virtual Reality Avatar Therapy for People Hearing Voices No drug interventions treatment Not Available recruiting NCT01576640
Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia No drug interventions treatment 4 terminated NCT00796640
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations No drug interventions treatment 1 completed NCT01090440
Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects No drug interventions treatment 1 completed NCT01485640
Lurasidone Extended Use Study No drug interventions treatment 3 completed NCT02845440
Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness No drug interventions treatment Not Available completed NCT04526067
In-person vs. Remote Wellness Support No drug interventions treatment Not Available completed NCT00986167
Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry No drug interventions treatment 4 unknown_status NCT00540267
Bone Density in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00458367
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice No drug interventions Not Available Not Available completed NCT01324167
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00328367
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia No drug interventions treatment 4 completed NCT02722967
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System No drug interventions treatment 2 completed NCT06361667
Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") No drug interventions treatment Not Available recruiting NCT02374567
Pharmacovigilance in Gerontopsychiatric Patients No drug interventions treatment 3 terminated NCT03062267
Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness No drug interventions treatment Not Available completed NCT00801567
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation No drug interventions Not Available Not Available withdrawn NCT03814967
Effects of Brain Stimulation on Higher-Order Cognition No drug interventions basic_science Not Available recruiting NCT00791167
A Study of the Dose Proportionality of Extended Release Paliperidone No drug interventions treatment 1 completed NCT00916201
Evaluation Study of New Compounds With Potential Use in Schizophrenia No drug interventions treatment 1 unknown_status NCT01654601
A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg No drug interventions basic_science 1 completed NCT04959201
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia No drug interventions treatment 2 recruiting NCT04332601
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT00500201
A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. No drug interventions treatment 1 completed NCT01592201
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug No drug interventions treatment 4 terminated NCT02021201
The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia No drug interventions basic_science 4 terminated NCT02354001
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia No drug interventions treatment 4 completed NCT01667601
Mindfulness-based Illness Management Program for Schizophrenia No drug interventions treatment Not Available completed NCT00640601
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia No drug interventions treatment 3 completed NCT01015001
A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine No drug interventions treatment 3 completed NCT02905604
Magnetic Stimulation of the Brain in Schizophrenia or Depression No drug interventions treatment Not Available completed NCT00453804
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) No drug interventions treatment 4 completed NCT05192304
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia No drug interventions treatment 1 unknown_status NCT01384604
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders No drug interventions Not Available Not Available completed NCT00319904
The Partners Genetics Collaborative Study of Schizophrenia No drug interventions Not Available Not Available completed NCT00713804
Impact of Genetic Counseling for Individuals With Mental Illness No drug interventions Not Available 3 completed NCT05341804
Cognitive and Balance Dual Task Training for People With Schizophrenia No drug interventions treatment Not Available completed NCT00362804
Tetrabenazine for Partial Responders No drug interventions treatment Not Available completed NCT00300404
Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression treatment 3 completed NCT04859504
Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia No drug interventions treatment Not Available recruiting NCT00921804
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients No drug interventions treatment 2 completed NCT02879604
Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available completed NCT00498004
Quality of Life (QOL) in Female Patient With Schizophrenia No drug interventions treatment 4 terminated NCT00366704
Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint No drug interventions treatment 3 terminated NCT03883204
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up No drug interventions treatment 4 unknown_status NCT05030272
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings No drug interventions treatment Not Available recruiting NCT00859872
Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia No drug interventions treatment 4 completed NCT01559272
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia No drug interventions treatment 1 completed NCT00000372
Glycine and D-Cycloserine in Schizophrenia treatment 3 withdrawn NCT01626872
Long-Term Study of MP-214 in Patients With Schizophrenia No drug interventions treatment 2 / 3 completed NCT00246272
An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone treatment 3 completed NCT00645372
A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients No drug interventions treatment 3 completed NCT01312272
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia? No drug interventions treatment Not Available completed NCT02392468
Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers No drug interventions treatment 1 completed NCT03648268
Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia No drug interventions basic_science Not Available completed NCT01487668
Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders No drug interventions health_services_research Not Available completed NCT00108368
The Effects of Risperidone and Olanzapine on Thinking treatment 4 completed NCT01655368
Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM) No drug interventions treatment Not Available completed NCT03437668
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia No drug interventions treatment 2 / 3 active_not_recruiting NCT00001768
Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) treatment 3 completed NCT00272168
The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI No drug interventions treatment Not Available completed NCT00597168
Quality of Life in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT06118268
iTBS to Enhance Social Cognition in People With Psychosis No drug interventions treatment Not Available recruiting NCT02804568
A Phase 1 Safety Study in Adults With Schizophrenia No drug interventions treatment 1 completed NCT04846868
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) No drug interventions treatment 3 active_not_recruiting NCT04430868
Lifestyle Redesign For Schizophrenia No drug interventions treatment Not Available unknown_status NCT00278668
ECT Schizophrenia Serotonin Study No drug interventions Not Available Not Available unknown_status NCT01730768
A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients No drug interventions treatment 2 completed NCT00083668
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia treatment 3 completed NCT04221269
Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders No drug interventions treatment Not Available completed NCT05011669
The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia No drug interventions treatment 4 completed NCT00101569
Aripiprazole Oral Acceptability Trial treatment 3 completed NCT03187769
Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder No drug interventions treatment 3 completed NCT01786369
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. No drug interventions Not Available Not Available completed NCT00210769
A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia treatment 3 completed NCT00711269
Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia No drug interventions treatment 3 completed NCT04291469
Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT00661869
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness No drug interventions supportive_care Not Available completed NCT00089869
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia treatment 1 / 2 completed NCT02186769
An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 1 completed NCT03005769
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy No drug interventions Not Available Not Available completed NCT00963846
Huperzine for Cognitive and Functional Impairment in Schizophrenia No drug interventions treatment 2 completed NCT05528146
Effects of Psyllium on Constipation in Schizo-phrenic: A Randomized Controlled Crossover Trial No drug interventions prevention Not Available unknown_status NCT00300846
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients No drug interventions treatment 4 completed NCT02634346
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study) No drug interventions treatment 3 completed NCT00666146
Familial Schizophrenia and Spectrum Personality Disorders No drug interventions Not Available Not Available completed NCT00403546
High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms No drug interventions treatment 3 completed NCT05480046
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse No drug interventions Not Available Not Available recruiting NCT03076346
Neural Biomarkers of Clozapine Response No drug interventions Not Available Not Available completed NCT06253546
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia No drug interventions treatment 1 recruiting NCT00463346
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism No drug interventions treatment 3 completed NCT00915512
A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia No drug interventions treatment 4 completed NCT01548612
Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia No drug interventions treatment 2 completed NCT03793712
Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia No drug interventions treatment 2 terminated NCT01752712
Oxytocin and CBSST for People With Schizophrenia No drug interventions treatment Not Available completed NCT03514212
Promoting Physical Activity in People With Schizophrenia. No drug interventions other Not Available completed NCT05703412
Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness No drug interventions treatment Not Available enrolling_by_invitation NCT05542212
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia No drug interventions treatment Not Available recruiting NCT00295412
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients No drug interventions Not Available 4 completed NCT00768612
Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia No drug interventions treatment 2 withdrawn NCT01776112
Enhancing Synaptic Plasticity and Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT01614912
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02220712
A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia No drug interventions other 1 completed NCT00418912
Family Study in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00460512
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia No drug interventions treatment 3 completed NCT03999112
Effect of Metacognitive Therapy on Negative Symptoms: a Case Series No drug interventions treatment Not Available unknown_status NCT01575912
Past Pain Experience and Perception of Experimental Pain No drug interventions Not Available Not Available completed NCT01491412
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia No drug interventions Not Available Not Available completed NCT05966610
Bizarreness and Anomalous Self Experiences in Schizophrenia No drug interventions Not Available Not Available recruiting NCT00718510
L-arginine in Treatment as Usual in Schizophrenia No drug interventions treatment Not Available completed NCT03756610
Transcranial Alternating Current Stimulation (tACS) for Cognitive Impairments in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT01511510
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers No drug interventions basic_science 1 completed NCT05658510
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) No drug interventions treatment 3 active_not_recruiting NCT01098110
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) No drug interventions treatment 3 completed NCT02342210
Mindfulness Group-based Intervention for Early Psychosis: A Pilot Study No drug interventions treatment Not Available completed NCT04911010
Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder No drug interventions treatment Not Available recruiting NCT00466310
Metabolic Signatures and Biomarkers in Schizophrenia No drug interventions treatment 1 completed NCT03872310
Cognitive Enhancement on Working Memory in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01545310
A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia No drug interventions Not Available 1 completed NCT02118610
Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity No drug interventions treatment Not Available completed NCT03217110
Cerebellar Stimulation and Cognitive Control No drug interventions basic_science Not Available recruiting NCT04870710
Feasibility Electrical Stimulation Study for Visual Hallucinations No drug interventions treatment Not Available completed NCT05527210
Prebiotic Treatment in People With Schizophrenia No drug interventions other Not Available recruiting NCT06372210
A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion No drug interventions other Not Available completed NCT05973110
Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis No drug interventions treatment Not Available recruiting NCT03280810
Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia No drug interventions basic_science Not Available completed NCT00216281
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia No drug interventions treatment 3 terminated NCT03355781
Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology No drug interventions Not Available Not Available completed NCT03056781
Emotional Response in Psychiatric and Control Participants No drug interventions basic_science Not Available completed NCT05359081
A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan No drug interventions treatment 3 terminated NCT04846881
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) No drug interventions treatment 3 active_not_recruiting NCT01730781
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning No drug interventions Not Available Not Available recruiting NCT00567281
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study No drug interventions device_feasibility Not Available completed NCT02336581
Researching the Effectiveness of Acceptance-Based Coping During Hospitalization No drug interventions treatment Not Available completed NCT00159081
One Year Drug Treatment in First-Episode Schizophrenia treatment 4 completed NCT04867681
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia No drug interventions other Not Available recruiting NCT00796081
A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder No drug interventions treatment 1 completed NCT01526395
Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital No drug interventions supportive_care Not Available completed NCT04251195
Verbal Memory Training Using Virtual Reality in Schizophrenia No drug interventions treatment Not Available completed NCT00114595
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia treatment 4 completed NCT03369795
Add-on Methotrexate for the Treatment of Schizophrenia No drug interventions treatment 2 unknown_status NCT04929795
Effects of Music Beat on Motor Function in Individuals at Risk for Psychotic Onset and Schizophrenia Patients No drug interventions treatment Not Available recruiting NCT02383095
Efficiency of Art-therapy in Psychotic Disorders No drug interventions treatment Not Available terminated NCT02435095
Antipsychotic Induced Structural and Functional Brain Changes No drug interventions treatment 4 terminated NCT00999895
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT01946295
Famotidine in Schizophrenia No drug interventions treatment 2 / 3 unknown_status NCT00728195
An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia No drug interventions treatment 2 completed NCT01075295
Prevention of Weight Gain in Early Psychoses No drug interventions prevention Not Available completed NCT00222495
A Comparative Study of New Medications for Psychosis in Adolescents treatment Not Available completed NCT00698295
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication No drug interventions Not Available Not Available unknown_status NCT03048695
Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia No drug interventions treatment Not Available completed NCT06474195
Cue-based Intervention in Prospective Memory and Medication Adherence. No drug interventions supportive_care Not Available recruiting NCT04001114
Cigarette Smoking in Smokers With and Without Schizophrenia No drug interventions basic_science Not Available recruiting NCT00617214
Schizophrenic Patients Taking Part in Integrated Care Program No drug interventions Not Available Not Available terminated NCT04578314
RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations No drug interventions treatment Not Available completed NCT00589914
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02588014
The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02936414
Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients No drug interventions treatment Not Available completed NCT05440955
tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT00192855
Entacapone Augmentation for Schizophrenia treatment Not Available completed NCT02765555
First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 No drug interventions treatment 1 completed NCT03548155
Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00937755
The Study of Atypical Antipsychotics-induced Metabolic Disturbances No drug interventions Not Available Not Available completed NCT05756855
Young Adults with Violent Behavior During Early Psychosis No drug interventions health_services_research Not Available recruiting NCT01629355
Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder No drug interventions Not Available Not Available completed NCT06038955
Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders No drug interventions treatment Not Available recruiting NCT03810755
EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies No drug interventions treatment Not Available completed NCT00810355
Cognitive Behavior Therapy and Work Outcome No drug interventions treatment Not Available completed NCT01678755
A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia No drug interventions treatment 2 completed NCT02404155
Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) No drug interventions treatment Not Available completed NCT00044655
Switching Medication to Treat Schizophrenia treatment 4 completed NCT02144155
Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia No drug interventions prevention Not Available terminated NCT00191555
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment treatment 4 completed NCT00498550
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual No drug interventions treatment 4 completed NCT00520650
Health Evaluation of Abilify Long-term Therapy No drug interventions treatment 4 completed NCT00930150
Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network No drug interventions treatment 4 completed NCT00018850
5HT3 Antagonism and Auditory Gating in Schizophrenia treatment Not Available completed NCT01082250
The Bioequivalence Of Two Different Lurasidone Formulations In Patients No drug interventions Not Available 1 completed NCT06397950
Correlates of Fatigue in People With Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting NCT03407950
Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia No drug interventions treatment Not Available withdrawn NCT04109950
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia No drug interventions treatment 3 terminated NCT04618250
Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) No drug interventions health_services_research Not Available completed NCT01318850
Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through Functional Magnetic Resonance Imaging No drug interventions treatment Not Available completed NCT04968223
Neural Correlates of Social Touch and Interoceptive Perception as Potential Biomarker for Impaired Social Functioning No drug interventions Not Available Not Available recruiting NCT00130923
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder treatment 4 completed NCT00466323
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. No drug interventions treatment Not Available completed NCT00515723
Glucose and Lipid Metabolism on Antipsychotic Medication No drug interventions treatment Not Available completed NCT00158223
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia treatment 4 completed NCT02964923
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00981123
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia No drug interventions Not Available Not Available completed NCT00431223
Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training No drug interventions treatment Not Available completed NCT00520923
A Study for Patients With Schizophrenia No drug interventions treatment 2 completed NCT05258123
Ginkgo Biloba Extract in the Treatment of Schizophrenia No drug interventions treatment Not Available completed NCT02174523
Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects No drug interventions other 1 completed NCT00322023
Safety and Effectiveness of D-serine in Schizophrenia No drug interventions treatment 2 completed NCT02476708
A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia No drug interventions treatment Not Available terminated NCT01123408
Clozapine and Olanzapine Treatment of Aggression No drug interventions treatment Not Available completed NCT00998608
Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia No drug interventions treatment 4 terminated NCT06562608
Anticholinergic Deprescription in Schizophrenia No drug interventions treatment 4 not_yet_recruiting NCT02156908
D-serine and Cognitive Remediation in Schizophrenia No drug interventions treatment 2 completed NCT01544608
Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia No drug interventions Not Available Not Available completed NCT01389908
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder No drug interventions supportive_care Not Available unknown_status NCT01596608
Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder No drug interventions treatment Not Available completed NCT06036108
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia No drug interventions treatment 1 recruiting NCT04143308
The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia No drug interventions other Not Available completed NCT00914238
Extended Specialized Assertive Intervention for First Episode Psychosis No drug interventions treatment Not Available completed NCT02095938
Association of Amisulpride Response in Schizophrenia With Brain Image No drug interventions basic_science 4 unknown_status NCT00205738
Janssen - Glucose Regulation/Risp/Olanz treatment Not Available completed NCT00049738
Screening for Childhood-Onset Psychotic Disorders No drug interventions Not Available Not Available terminated NCT06044038
Exercise Intervention for People With Schizophrenia (CREW) No drug interventions prevention Not Available recruiting NCT00183443
Treatment of Mania Symptoms With Drug Therapy treatment 3 completed NCT04030143
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder No drug interventions treatment 1 / 2 completed NCT00524043
An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia No drug interventions treatment 4 completed NCT04624243
Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008) No drug interventions treatment 2 completed NCT04519099
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia treatment 3 recruiting NCT01359293
Effects of Paliperidone Palmitate Versus Oral Antipsychotics on Clinical Outcomes and MRI Measures treatment Not Available unknown_status NCT01987050
Intranasal Oxytocin in Schizophrenia Patients treatment 3 unknown_status NCT02455349
Improving Negative Symptoms and Community Engagement in Veterans With Schizophrenia No drug interventions treatment Not Available recruiting NCT01458379
Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia treatment 4 not_yet_recruiting NCT00692679
FMRI of Cholinergic Mechanisms in Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting